Identification of P. falciparum targets for transmission blocking interventions by Ταξιάρχη, Χρυσάνθη
 
 
Identification of P. falciparum targets 
for transmission blocking interventions 
 
 Ταυτοποίηση πρωτεϊνών στόχων του παρασίτου της 
ελονοσίας Plasmodium falciparum για την ανάπτυξη 
καινοτόμων μεθόδων διακοπής της μετάδοσης της 
ασθένειας 
 
 
Diploma Project  
of 
 
Chrysanthi Taxiarchi 
 
 
 
 
 
 
Department of Biochemistry and Biotechnology 
Faculty of Life Sciences 
University of Thessaly 
and 
Division of Cell and Molecular Biology 
Faculty of Natural Sciences 
Imperial College London 
 
 
London 2012 
Institutional Repository - Library & Information Centre - University of Thessaly
09/12/2017 03:13:53 EET - 137.108.70.7
1 
 
 
 
 
Three-member Board Signature 
Vlachou Dina - PhD 
Principal Investigator, Senior Research Fellow 
Division of Cell and Molecular Biology 
Department of Life Sciences 
Imperial College London  
 
Mathiopoulos Konstantinos – Associate Professor,  
Molecular Biology  
Department of Biochemistry and Biotechnology, 
University of Thessaly 
 
Mossialos Dimitrios - Assistant Professor, Microbial 
Biotechnology  
Department of Biochemistry and Biotechnology, 
University of Thessaly 
 
 
 
 
 
 
 
 
 
 
 
 
 
Institutional Repository - Library & Information Centre - University of Thessaly
09/12/2017 03:13:53 EET - 137.108.70.7
2 
 
ABSTRACT  
 
Plasmodium parasite, the causative agent of one of the deadliest diseases worldwide, malaria, 
must complete a successful developmental migration through Anopheles mosquitoes before 
transmission to human hosts. The current thesis demonstrates the identification and 
characterisation of four novel P. falciparum genes, Pf_c01, Pf_c53, Pf_c02 and Pf_c57, which 
have crucial roles in the sporogonic and sexual development of Plasmodium. The identified 
genes are differentially regulated during the developmental stages of midgut invasion and 
ookinete-to-oocyst transition, which represent a critical bottleneck in Plasmodium’s lifecycle. 
Detailed in vivo and in vitro phenotypic analysis, following disruption of each of the four genes, 
revealed a severe reduction of the mosquito infection intensities. Interestingly, gene deletion 
does not affect the sexual development from gametogenesis and fertilization until ookinete (the 
motile invasive zygote) formation. Pf_c02 and Pf_c57 products are putative membrane proteins 
and are likely to interact with mosquito midgut molecules, facilitating parasite’s traverse through 
the mosquito midgut. This study identified four novel key regulators of the parasite’s sexual and 
sporogonic development contributing in the elucidation of fundamental questions about the 
parasite’s development inside its mosquito vector and concurrently providing two potential 
targets for transmission blocking interventions. 
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ΠΕΡΙΛΗΨΗ 
 
Το παράσιτο Πλασμώδιο (Plasmodium) αποτελεί τον αιτιολογικό παράγοντα μιας εκ των πιο 
θανατηφόρων νόσων παγκοσμίως, της ελονοσίας. Το Πλασμώδιο αναπαράγεται και 
πολλαπλασιάζεται υποχρεωτικά μέσα στον φορέα του, Ανωφελές (Anopheles) θηλυκό κουνούπι, 
πριν τη μετάδοση στον ανθρώπινο ξενιστή. Η παρούσα διπλωματική εργασία παρουσιάζει την 
ταυτοποίηση και το χαρακτηρισμό τεσσάρων νέων γονιδίων του P. falciparum, τα Pf_c01, 
Pf_c53, Pf_c02 και Pf_c57, τα οποία έχουν καίριο ρόλο στη σπορογονική και σεξουαλική 
ανάπτυξη του Πλασμωδίου. Τα συγκεκριμένα γονίδια παρουσιάζουν διαφορική ρύθμιση της  
έκφρασής τους κατά τα αναπτυξιακά στάδια της διαπέρασης του μεσεντέρου και της μετατροπής 
του ωοκινέτη σε ωοκύστη, στάδια που αποτελούν κρίσιμο στενωπό στον κύκλο ζωής του 
Πλασμωδίου. Λεπτομερής in vivo και in vitro φαινοτυπική ανάλυση, που ακολούθησε τη 
στοχευμένη απαλοιφή καθενός εκ των τεσσάρων γονιδίων, αποκάλυψε μια σφοδρή μείωση στην 
ένταση των μολύνσεων των κουνουπιών. Είναι ιδιαίτερα ενδιαφέρον ότι η γονιδιακή απαλοιφή 
δεν επηρεάζει τη σεξουαλική ανάπτυξη από το στάδιο της γαμετογένεσης και της γονιμοποίησης 
μέχρι το στάδιο του σχηματισμού του ωοκινέτη (η κινητή και διεισδυτική μορφή ζυγωτού). Τα 
προϊόντα των γονιδίων Pf_c02 και Pf_c57 αποτελούν πιθανές μεμβρανικές πρωτεΐνες και  
ενδεχομένως αλληλεπιδρούν με μόρια του κουνουπιού, διευκολύνοντας τη διάσχιση του 
μεσεντέρου του κουνουπιού από το παράσιτο. Στη συγκεκριμένη μελέτη ταυτοποιήθηκαν 
τέσσερις ρυθμιστές «κλειδιά» της σεξουαλικής και σπορογονικής ανάπτυξης του παρασίτου, 
συμβάλλοντας στη διαλεύκανση θεμελιωδών ερωτημάτων σχετικά με την ανάπτυξη του 
παρασίτου μέσα στο κουνούπι-φορέα και ταυτόχρονα παρέχοντας δύο πιθανούς στόχους για την 
ανάπτυξη καινοτόμων μεθόδων διακοπής της μετάδοσης της ασθένειας.  
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CHAPTER 1: INTRODUCTION 
 
1.1 Malaria: a contemporary scourge dating back to antiquity 
 
1.1.1 Historical overview of malaria 
 
For more than four millenniums, malaria or a disease that had the same characteristics with 
malaria has had a strong influence on humanity. References to what was almost certainly malaria 
occur date back to 2700 BC in China, when Nei Ching documented malaria symptoms in his 
medical writings: The Canon of Medicine. In the 4th century BCE, one of the most outstanding 
figures in the history of medicine, Hippocrates, based on studies in Egypt, was first to make 
connection between nearness of stagnant bodies of water and occurrence of fevers in local 
population, noting the principle symptoms of malaria. 
The discovery of the causative agents of malaria was made in 1880 by Charles Louis 
Alphonse Laveran, a French physician, after microscopic detection of parasites a blood smear, 
taken from a patient who had just died of malaria, at a military hospital in Algeria (Bruce-
Chwatt, 1987). Although Laveran did not achieve to determine the introduction of these 
protozoans into the human body, he was awarded with Nobel Prize for Physiology or Medicine 
in 1907, for the first discoveries of protozoan diseases and is credited with describing the 
etiologic agent of malaria.  
Since antiquity, it was observed that malarial symptoms occurred frequently in close 
proximity to stagnant water and marshes, leading the Romans to pioneer efforts to drain swamps, 
in order to restrict the spread of what was called “Roman fever”, and the Italians to name this 
disease “mal’ aria”, which means “bad air” in Latin (Sallares R.,2002). Despite this significant 
datum, the mode of transmission of the disease was not determined until 1897, when Ronald 
Ross, a British military doctor, noticed the malarial parasite in the gastrointestinal tract of 
mosquitoes, while working in India. This observation led Ross to demonstrate that the parasite 
transmission between its vertebrate hosts is facilitated by mosquitoes. For this breakthrough 
discovery, he received the Nobel Prize for Physiology or Medicine in 1902.  
The first demonstration of the transmission cycle of human malaria parasite in the 
mosquito was introduced by the Italian malariologists, Giovanni Battista Grassi, Amico 
Bignami, Giuseppe Bastianelli, one year after the Ross’ discovery, in 1898. 
(http://www.cdc.gov/malaria/about/history/) 
Human malaria is nowadays known that is caused by protozoan parasites belonging to the 
phylum Apicomplexa in the class of Sporozoa, order Coccidiida, suborder Haemosporidiidae, 
family Plasmodiidae and genus Plasmodium which infect two different species, Anopheles 
mosquito vectors and human hosts, at different stages of the parasite life cycle. Transmission of 
Plasmodium is mediated by the female Anopheles vector feeding on the blood from an 
uninfected human after having previously blood-fed on a malaria human carrier. 
 
 
 
 
 
 
 
Institutional Repository - Library & Information Centre - University of Thessaly
09/12/2017 03:13:53 EET - 137.108.70.7
10 
 
1.1.2 Diagnosis and symptoms 
 
Diagnosis of malaria is comprised of the identification of 
malaria parasites or metabolic products in the blood of the 
patient. The mainstay method for diagnosis is the microscopic 
examination of thick and thin Giemsa stained blood smears 
for possible parasite presence. Thin films are preferred when 
species determination is required because the parasite 
morphology is well maintained using this method, but thick 
films allow the detection of lower parasitaemia. Although the 
usage of microscopy diagnosis is widespread, deficiency in 
microscopic facilities and experienced microscopists is usual 
in malaria endemic regions (Bell et al., 2006). 
Also, antigen-detecting Rapid Diagnostic Tests (RDT) are commercially available. RDTs are 
accurate in detecting malaria parasites but their threshold of detection is higher than that of 
traditional microscopy (Wilson, 2012). Although they do not require laboratory setting and staff, 
they are cost-effective, and, thus, they are not yet widespread applied in endemic regions.  This 
lack of reliable diagnostic tools and specialised staff in the endemic areas usually leads to late 
and inaccurate diagnosis based on the non-specific symptoms of the disease (Bell et al., 2006). 
 The clinical manifestation of malaria varies, depending on a combination of parasite, host 
and socio geographical factors. The strain of the parasite, the age, pregnancy, genetic 
background, previous exposure etc. of the patient can affect the total clinical outcome and the 
host immune response (Miller et al., 2002; Greenwood et al., 1991). This is the reason why 
malaria develops into non-specific symptoms. Typically, the incubation period following 
infection lasts, approximately, 8-12 days for falciparum malaria but can be longer for other types 
of infections (Fairhust et al., 2010). The primary symptoms, shared by all types of malaria, are 
called “malaria argue” and overlap with the signs of flu (Bartoloni and Zammarchi, 2012). These 
symptoms occur cyclically every 2-3 days and are three stages of fever (paroxysm), beginning 
with shivering, then sudden rise of the temperature and, finally plenteous sweating usually 
accompanied fatigue, convulsions, emesis, cephalalgia, arthralgia, haemolytic anemia, 
haemoglobinuria and retinopathy (Beare et al., 2006). Depending on the associating symptoms, 
the progress of the disease and the type of infection, three types of malaria manifestations can be 
distinguished: severe malaria which progresses rapidly and usually leads to cerebral malaria 
or/and respiratory distress and, finally to death within days if not treated (mostly caused by P. 
falciparum); chronic malaria which presents clinical relapses months after the infection, arisen 
from dormant liver parasites (present in P. vivax and P. ovale); malaria during pregnancy which 
affects severely both mother and fetus (mostly caused by P. falciparum) (Breman et al., 2004).  
 
 
1.1.3 Impact of the disease on Global health 
 
Although malaria is an ancient disease, and, nowadays is preventable and treatable, it still 
remains a worldwide deadly scourge due to environmental disturbance, malnutrition and the 
failure of drugs previously used to combat the disease (http://www.malaria.org/lifehealth.html).  
The latest World Malaria Report compiled by the World Health Organisation (WHO), 
includes 104 countries and territories in which malaria is classified as an endemic disease, 99 of 
which present ongoing malaria transmission and 5 are in prevention of reintroduction phase. In 
these countries, 3.3 billion people are estimated to have been at risk of malaria infection in 2011, 
while the highest risk of transmission is localised in sub-Saharan Africa (Figure 1.2). Although 
Figure 1.1. Blood sample collection 
for microscopic diagnosis 
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there is a reduction in the numbers estimated in 2010, still, 26 million malaria cases leading to 
approximately a hundred thousand deaths, worldwide, were reported in 2011, maintaining 
malaria as one of the world’s leading infectious killers.  
The two most severely affected groups are young children and pregnant women. More 
specifically, the percentage of deaths caused by malaria in children under the age of five is 
estimated in 85% of the annual report, which corresponds to 20% of all childhood deaths in sub-
Saharan Africa (Aregawi et al., 2008). Foetal and infant mortality, also, increases, due to malaria 
infection during pregnancy. Even when survival is succeeded, malaria can cause several health 
problems such as acute anaemia in women and children, low birth weight in infants and chronic 
neurological and physical disability.  
Apart from the fact that malaria impacts individuals, it has, also, a huge burden in 
communities and the economy. At present, the overwhelming majority of the countries that face 
high rates of malaria endemism also face poverty. Malaria is judged as a disease of poverty, 
being a cause and a consequence of poverty at the same time (Gollin and Zimmermann, 2007). 
Malaria afflicting countries present 1.3% reduction in per capita income (Gallup and Sachs 
2001) while they cannot afford the cost of preventing and controlling malaria and the education 
needed in order to succeed this aim (Chima,Goodman and Mills, 2003), resulting in a vicious 
cycle linking the disease to poverty and poverty to the disease.  
 
 
Figure 1.2. The spatial distribution of Plasmodium falciparum malaria endemicity in 2010. Model-based 
geostatistics (MBG) point estimates of the age-standardised annual mean P. falciparum parasite rate in 2-10 
year olds (PfPR2-10), for 2010, within the spatial limits of stable P. falciparum malaria transmission. Areas of 
no risk and unstable risk (PfAPI < 0.1 %o) are also shown in light and dark grey, respectively. Modified from 
(Gething, Patil and Smith et al., 2011)  
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1.2 Malaria cause and lifecycle 
 
1.2.1 The etiologic agent of the disease: Plasmodium parasite 
 
Plasmodium is a genus of Apicomplexan parasites, initially described by Ettore 
Marchiafava and Angelo Celli, in 1885. Up to date, over 200 species of Plasmodium genus are 
recognized while new species continue to be described (Perkins and Austin, 2008). Five 
Plsamodium species have long been recognised to naturally cause malaria in humans: P. 
falciparum, P. malariae, P. ovale, P. vivax and P. knowlesi (Mueller et al., 2007; Collins, 2012). 
Among these, the most widespread and deadliest is P.falciparum with a proportion of 75% of the 
total infections, worldwide (Nadjm and Behrens, 2012) and the predominant Plasmodium species 
in sub-Saharan Africa. Outside Africa, the species responsible for the majority of malaria cases 
is P. vivax. Generally, there are hundreds of types of malaria affecting non-human vertebrates, 
very few of which have been reported to affect humans as well, but with no significant public 
health imprint (P. knowlesi infections excluded) (Collins, 2012).  
Plasmodia are unicellular obligate eukaryotic organisms which may display some 
structural differences during their similar lifecycle, between the different species. Characteristic 
organelles and structures, such as the apical prominence, rhoptries, polar rings and micronemes, 
apicoplasts etc. are present in all Plasmodium species as they are essential for all Apicomplexa 
during specific stages in their lifecycle (Figure 1.3).  
The genomes of five Plasmodium species (P. falciparum, P. knowlesi, P.vivax, P. berghei 
and P. yoelii) have been sequenced, and others are currently underway, revealing a consistent 
distribution of the, approximately, 25 megabases genome across 14 chromosomes, the length of 
which varied between 500 kilobases and 3.5 megabases. This has opened the gate to promising 
and effective studies including comparative and functional genomics, at the level of 
transcriptome and proteome. Also, due to the high risk of working with the human pathogen, P. 
falciparum, and the lack of a non-primate animal model compatible with P. falciparum (Herrera 
et al., 2002), research has focused on the study of rodent model parasites, the most extensively 
characterised of which is P. berghei. P. berghei, the life-cycle progression of which presents 
high similarity with P. falciparum, constitutes an important model parasite for vaccine, 
pathogenesis, drug, transmission studies and studies on the parasite biology.  
 
 
 
 
 
 
 
 
 
Figure 1.3. Characteristic morphology and distinct organelles of P. falciparum (merozoite stage).  
a) Electron photograph  (n=nucleus, ap=apical prominence, d=dense granule, r=rhoptry 
b) Schematic  representation   
Adapted from (Kats et al., 2006) 
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1.2.2 The transmission vector: Anopheles mosquitoes 
 
As malaria is naturally transmitted to humans by female mosquitoes of the genus 
Anopheles, the study of the Anopheles vectors, along with the study focusing on the parasite, is 
essential.  
Anopheles is a genus of mosquito initially described and named by J. W. Meigen in 1818. 
Currently, approximately 460 species of mosquitoes belonging to the genus Anopheles are 
recognised, 30 to 40 of which commonly transmit effectively the five species of Plasmodium 
parasites that cause human malaria, depending on the environment of the endemic region. 
Among these, Anopheles gambiae with its sibling, A. arabiensis, wins the distinction for 
predominantly transmitting the deadliest parasite P. falciparum. Anophelines are found 
worldwide except Antarctica and, specifically, malaria transmitting species are also found in 
areas where malaria has been eliminated, raising the risk of reintroduction of the disease.  
(http://www.cdc.gov/malaria/about/biology/mosquitoes/).  
Some species of Anopheles also can serve as vectors for the transmission of other 
diseases, apart from malaria and, also, the susceptibility of malaria infection varies between the 
different species of Anopheles (even within the same species). These facts are currently under 
investigation, as they could generate promising perspectives for eliminating malaria.  
 
• Life stages (Figure 1.4) 
Like all mosquitoes, Anophelines require a transition through four stages of development 
in their lifecycle: egg, larva, pupa, and imago (when it attains adultness). The pre-adult stages are 
aquatic and, depending on the species and the environmental temperature, they can last 
approximately 5 to 14 days. During the adult stage, only the female Anopheles mosquito is able 
to act as malaria vector. The maximum lifespan of adult females is a month (or more in 
captivity) but, natural conditions, usually, do not allow them to live more than 1-2 weeks. 
 
Eggs:  Adult females lay 50–200 eggs (dimensions about 0.5 × 0.2 nm) per opposition. Eggs are 
laid singly and directly on water where they are able to float on either side. They display no 
resistance to drying and hatch within 2–3 days (depending on the ambient temperature). 
 
Larvae: Anopheles larvae prefer unpolluted water for their development, although they have the 
ability to grow in a broad range of habitats. They present a well-developed head, including 
mouth brushes useful for their feeding, a nine-segment abdomen and a broad thorax. Anopheles 
larvae position their bodies in parallel with the surface of the water due to their lack of 
respiratory siphon and the presence of spiracles located on the eighth abdominal segment. They 
feed on bacteria, algae, and other microorganisms and organic matter present in the surface 
microlayer. Larvae development undergoes four instars, before they metamorphose into pupae. 
At the end of each instar, when molting takes place, the larvae shed their exoskeletons, to allow 
for further growth.  
 
Pupae: Pupa stage is a resting and non- feeding stage with duration of 2-3 days in temperate 
environment. Viewing form the side discloses a comma shape of pupae. The head and thorax are 
merged into a cephalothorax with the abdomen curving around underneath. Pupae’s respiratory 
system consists of trumpets located on the cepahalothoraces which force them to come to the 
surface to breath. During the metamorphosis to adult, the dorsal surface of the cephalothorax 
ruptures and the adult mosquito emerges. 
Institutional Repository - Library & Information Centre - University of Thessaly
09/12/2017 03:13:53 EET - 137.108.70.7
14 
 
 
Adults: Like all mosquitoes, adult Anophelins’ bodies comprise of three sections: head, thorax 
and abdomen. The head’s exclusive functions are acquiring sensory information (eyes, antennae, 
maxillary pulps) and feeding (proboscis). The thorax is dedicated to locomotion, with three pairs 
of legs and a pair of wings assisting and the abdomen is specialized for food digestion and egg 
development (in females).  
Anopheles mosquitoes can be distinguished from other mosquitoes by the palps, which 
are as long as the proboscis, and by the presence of discrete blocks of black and white scales on 
the wings. Adults can also be identified by their typical resting position: males and females rest 
with their abdomens sticking up in the air rather than parallel to the surface on which they are 
resting. 
Male and female adults feed on nectar and other sources of glucose but only females 
require a blood meal following mating, which, after gradual digestion, will serve as a source of 
nutrients for the developing eggs. To which extend female of different Anopheles species prefer 
human blood (anthropophily) for their eggs production determines the efficiency of these species 
as human malaria vectors, making A. gambiae the dominant malaria vector in Africa.  
 
 
 
Figure 1.4 Schematic representation of Anopheles life cycle and anatomy 
A. The four developmental stages of Anopheles mosquitoes.  
B. External anatomy of a female Anopheles mosquito. (1. proboscis; 2. antenna; 3. Maxillary palpus; 4. eye; 5. 
occiput; 6. Anterior pronotal lobe; 7. scutum; 8. scutellum; 9. postnotum; 10. halter; 11. cercus; 12. wing; 13. 
femur; 14. tibia; 15. tarsus) 
C. Structure of a male and female Anopheles mosquito head  
D. Internal anatomy of a female Anopheles mosquito. (1. probocis; 2. Antenna; 3. Maxillary palpus; 4. Eye; 5. 
Occiput; 6. Anterior pronotal lobe;7. Mesonotum; 8. Scuttellum; 9. Postnotum; 10. Haltere; 11. Cerci; 12. 
Wing; 13. Femur; 14. Tibia; 15. Tarsus; 16. Pharynx; 17. Pharyngeal pump; 18. Oesophagus; 19. Dorsal 
diverticula; 20. Proventriculus; 21. Midgut; 22. Stomach; 23. Ovary; 24. Rectum; 25. Cerci; 26. atrium; 27. 
Spermatheca; 28. Oviduct; 29. malpighian tubules; 30. Ventral diverticulum; 31. Salivary glands; 32. Salivary 
duct; 33. Salivary pump.). Adapted from (Gilles et al. 1993) 
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1.2.3 Overview of the Plasmodium lifecycle 
 
In short, Plasmodium parasite utilises a binary host system during its multi-stage 
lifecycle, consisting of a series of sequential intracellular proliferation and extracellular invasion 
stages (Figure 1.5). During its lifecycle, the parasite infects a vertebrate host and a mosquito 
vector, passing through two phases in the vertebrate: the pre-erythrocytic cycle and the 
erythrocytic cycle, and one in the mosquito: the sporogonic cycle. 
When an infected female Anopheles mosquito feeds on a non-infected human, together 
with the saliva, Plasmodium parasites in the infectious form of sporozoites are injected into the 
human bloodstream and multiply within the hepatocytes as merozoites. Subsequently, the 
released merozoites invade the erythrocytes where they proliferate again resulting in more 
merozoites, capable of reinvasion of the red blood cells (asexual blood stages).  
Some of the blood stage parasites develop into male and female gametocytes, the parasite 
forms that are infectious to mosquitoes. Consequently, on the next blood meal of a non-infected 
Anopheles mosquito, these gametocytes are transferred into the mosquito midgut, where they 
undergo a sexual stage of reproduction, concluding in sporozoites inside the salivary glands. 
These sporozoites are able to infect another human host during the next blood meal of the 
mosquito. 
    
 
Figure 1.5. Distinct stages of the malaria parasite life cycle, divided between the mosquito vector where the 
sexual reproduction takes place and the human host where the asexual replication occurs. Detailed analysis in 
the two following sections. Source: http://www.euvaccine.eu/vaccines-diseases/diseases-poverty/malaria  
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1.3 A deep sight in the malaria life stages and the transmission chain 
 
1.3.1 Malaria vertebrate lifecycle and pathogenesis 
 
Plasmodium has a complex life cycle in humans, where the outcome is the malaria 
pathogenesis. During the uptake of a blood meal of a malaria infected female Anopheline on a 
non-infected human, infective sporozoites carried by the mosquito are in released in the 
bloodstream of the human with the insect’s saliva. Within 30 minutes, sporozoites are transferred 
via the bloodstream to the liver where they invade the hepatocytes and initiate schizogony. 
During the next 5 to 16 days, referring as incubation period, the sporozoites undergo asexual 
reproduction inside the hepatocytes and develop into exoerythrocytic schizonts, structures that 
can contain thousands of merozoites (NIAID, 2002).  
During the incubation period, the Plasmodium infection is completely asymptomatic. All 
the clinical effects of Plasmodium infection are caused after the rupture of mature schizonts and 
the release of the merozoites into the bloodstream, where they penetrate the red blood cells 
(RBCs) (Matuschewski, 2006).  
After 1-2 minutes of their release, merozoites invade the RBCs where they consume 
haemoglobin as a source of energy to pass from the initial endoerythrocytic stage, termed as ring 
form, and mature into trophozoites. The trophozoite within a red blood cell grows and forms a 
blood-stage schizont which undergoes another round of asexual proliferation, producing 6 to 36 
merozoites. Subsequently, the mature schizont ruptures destroying the erythrocyte and releasing 
the merozoites into the bloodstream, where they infect other RBCs. Apart from the burst of 
merozoites, the schizont rupture results, also, in the release of the metabolic products of the 
parasite into the patient’s circulation, causing paroxysm, and hemozoin, a pigment produced by 
the digestion of haemoglobin which accumulates in the organs of the patient.  
In P. vivax infections, some sporozoites do not immediately develop into schizonts, but 
instead form hypnozoites that remain dormant for several months to several years, until their 
reactivation leading to the generation of merozoites. Hypnozoites are responsible for long 
incubation and late relapses in P. vivax infections.  
After some cycles of infection, multiplication and bursting, infection of new RBCs by 
some of the merozoites, do not result in another asexual production of merozoites but in sexual 
differentiation in microgametocytes and macrogametocytes (male and female gametocytes, 
respectively). It has been recently demonstrated, in P. falciparum, that the developmental switch 
from asexual replication to sexual development initiates at the ring stage and that all merozoites 
from that ring parasite and later schizont are committed to form gametocytes upon invasion of 
new erythrocytes (Dixon et al., 2008). The gametocytes can be ingested by a female mosquito 
during a blood meal leading to Plasmodium developement inside the vector and malaria 
transmission. 
Out of the five species that cause human malaria, P. falciparum is the only one where 
severe and fatal pathogenesis frequently occurs (Pasvol, 2005). The reason for P. falciparum’s 
enhanced virulence, compared to other Plasmodium species, originates in the ability to invade 
not only reticulocytes (immature RBC) but also a large proportion of circulating RBCs and the 
great variety of the invasion pathways utilized for the penetration of RBCs. These privileges of 
P. falciparum make it capable of causing very high parasitaemia and reaching high 
multiplication rates and enhanced growth, compared to other species, resulting in a severe 
clinical outcome (Miller et al., 2002). 
The ability of P. falciparum to sequester is another important factor affecting its 
enhanced pathogenicity. As endoerythrocytic P. falciparum parasites grow, they modify the 
infected RBC surface, by expressing adherent ligands which allow gametocytes, trophozoites 
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and schizonts to bind receptors expressed by endothelial cells in the deep vascular beds of the 
brain, the placenta and other organs (Figure 1.6). As a consequence, sequestration to brain and 
placenta is proposed to participate in the occurrence of cerebral and placental malaria 
(Weatherall et al., 2002).  
 
 
 
 
Figure 1.6. Overview of the Plasmodium development inside the human host. The malaria parasite enters a 
vertebrate host, during the blood meal of an infected female mosquito by injection of infectious sporozoites. 
Sporozoites travel to the liver, where they invade and replicate in liver cells, resulting in thousands of daughter 
merozoites released into the bloodstream. These merozoites initiate a cycle of RBC invasion and intracellular 
replication. The parasites circulating within RBCs, express adherent ligands that enable the maturing parasite 
to bind to the endothelium of organs such as the brain, lungs and placenta. The parasitized RBCs develop into 
schizonts, which rupture to release a new set of merozoites and parasite metabolic products into the 
bloodstream and the asexual cycle continues causing severe pathogenesis. A subset of trophozoites 
differentiates into sexual progenitor cells, the gametocytes, which are ingested by another feeding mosquito, 
and therefore follow the sexual cycle in the insect. Adapted from (Schofield and Grau, 2005). 
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1.3.2 Malaria transmission life cycle – mosquito stage development 
 
As mentioned, gametocytes, the first sexually competent forms of Plamsodium 
development during its lifecycle, are essential for the transmission of malaria, as they are the 
springboard for the sporogonic cycle inside the Anopheles vector. Macrogametocytes and 
microgametocytes are produced inside the RBCs of the infected human host, by sexually 
commited trophozoites (Bruce et al., 1990; Mons B., 1986). Mature gametocytes (arrested in G0 
– inactivated) are transmitted from the human host to the female mosquitoes by an infected blood 
meal uptake, initialising the parasite journey in the mosquito. Inside the mosquito, the 
Plasmodium gametocytes undergo activation into gametes and fertilisation, and further transform 
to ookinetes, oocysts and finally sporozoites. The passing through these stages of sporogony 
comprises of processes characterised by differential gene transcription, protein expression, 
upregulation of biochemical pathways and, finally, morphological structure formation: 
gametogenesis, fertilisation and zygote formation, ookinete maturation and locomotion, midgut 
invasion, ookinete-to-oocyst transition, oocyst maturation and sporogony, sporozoite migration 
and salivary gland ivasion.   
 
 
Figure 1.7. Plasmodium migration in the mosquito host. The developmental lifecycle of Plasmodium in the 
mosquito starts with a female mosquito bite and blood meal on a malaria-infected vertebrate host; it ends with 
a new bite approximately three weeks later. The processes followed during the development of the parasite 
inside the mosquito vector are described in the text. Adapted from (Vlachou et al., 2006). 
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1.3.2.1 Gametogenesis 
 
Gametocytes ingested by a mosquito during a blood meal, are passively transferred into 
the mosquito midgut lumen where activation of the formation of gametes (gametogenesis) 
occurs, due to sensitivity of the gametocytes to environmental influence. The factors that initiate 
the gametogenesis are the presence of xanthurenic acid, a mosquito-derived molecule, in 
addition to drop in temperature and pH shift (Billker et al., 1997; Billker et al., 1998). Soon after 
the activation, an intracellular rise in Ca2+ concentration transduces the signal for the emergence 
of the gametes from the RBCs (McRobert et al., 2008). Following emergence, gametogenesis 
differentiates between male and female.  
 
Male gametogenesis:  
The mature male gametocyte includes few mitochondiria, apicoplasts and membrane 
bound vesicles, known as osmophillic bodies, while it lacks endoplasmic reticulum (ER). The 
main characteristic of it is an enlarged nucleus containing highly organised chromosomes, the 
kinetochores of which are attached to the Microtubule Organising Centre (MTOC) located on the 
cytoplasmic side of the nuclear envelope, via a nuclear pore (Sinden, 1998). 
Upon activation, male gametocytes undergo three rounds of endomitosis, reaching an 
octoploid value and resulting, after karyokinesis and cell division, in the release of eight haploid 
and highly motile, flagellated microgametes (Alano, Billker and Sherman, 2005; Sinden, 1998). 
The success of the nuclear and cell division, during microgametogensis, is accomplished by the 
formation of a cytoskeletal core of the flagellum, called axoneme, which has the ability to lead 
the haploid genome into the developing microgamete (Sinden, 1998). In the rodent malaria 
parasite P. berghei, it is demonstrated that the initiation of DNA replication is regulated by the 
signalling response to the XA dependent rise of Ca2+ concentration, mediated by the calcium-
dependent protein kinase 4 CDPK4 (Billker et al., 2004). Also, the stimulation of cytokinesis and 
release of microgametes depends on the function of mitogen-activated protein kinase 2, MAPK-2 
(Rangarajan et al, 2005; Tewari et al., 2005), while in P. falciparum it is shown that MAPK-2 
has no essential role in the mature male gamete development (Dorin-Semblat et al., 2007). This 
process, termed exflagellation, was observed by Laveran in 1880 and provided the first major 
clues that malaria was caused by a parasitic protozoan (Laveran, 1880). 
 
Female gametogenesis:  
In contrast to the male gametocyte, the mature female gametocyte has a small nucleus, a 
large number of osmophilic bodies and an extensive ER with increased ribosome production. 
Mitochondria, ribosomes, apicoplasts and mRNA are located in the cytoplasm (Sinden, 1998). 
The maturation process of the female gametocyte thus is a preparative stage for the extensive 
proteins synthesis associated with female gametocyte activation. 
Female gametogenesis does not require genome replication, giving rise to a single, large 
round-shaped and motionless gamete. It is proposed that the presence of a large number of 
osmophilic bodies, the generation of which depends on the gametocyte specific expression of 
Pfg377 in P. falciparum (Alano et al., 1995), is responsible for the efficient process of 
macrogamete formation (Sinden, 1998). 
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1.3.2.2 Fertilisation and zygote formation 
 
Fertilisation is dependent on the final stage of exflagellation, when exflagellation centres 
are generated. The emerging microgametes bind uninfected RBC, infected RBC and 
macrogametes, causing them to cluster around the exflagellating male gametocytes. The exact 
function of the exflagellation centres is not yet clear, but it is suggested that, due to their 
potential role in the enhancement of microgamete motility, they are important for the 
establishment of infection in the vector, (Eksi et al., 2006). During fertilisation, the 
microgametes bind on the surface of macrogametes, by expressing surface adherent proteins, 
Pfs230 (Eksi et al., 2006) and P48/45 (van Dijk et al., 2001), as demonstrated in P. falciparum.  
Fertilisation results in fusion of the plasmalemmas of the two gametes and entrance of the 
male nucleus and naked axoneme inside the female cytoplasm (Sinden et al., 1985) The two 
nuclei fuse, right after fertilization, in order to form a diploid spherical zygote (Aikawa et al., 
1984), which inherits the maternal gamete plasma membrane, cytoplasm, and intracellular 
organelles. Nuclear fusion in the zygote is followed by DNA replication and meiosis without 
nuclear division or cytokinesis occurring (Sinden et al., 1985), resulting in a tetraploid genome 
(Janse et al., 1986).   DNA replication during this meiotic event is regulated by the female-
specific expression of two NIMA (never in mitosis/Aspergillus) related kinases, Nek2 and Nek4 
(Reininger et al., 2005; Khan et al., 2005; Reininger et al., 2009).  
 
 
1.3.2.3 Ookinete maturation and locomotion  
 
Within 12-24 hours, the zygote gradually passes from spherical stage to elongated, retord 
stage, presenting a characteristic growing apical protrusion. The outcome of this transition is the 
first intravector invasive form of the Plasmodium, characterised by intense polarisation, a highly 
conserved subcellular organisationa and a unique form of locomotion, the mature crescent-
shaped ookinete.  
The development of the ookinete requires the generation of an extensive subpellicular 
microtubular network forming the associated MTOC, known as the apical polar ring, and the 
anterior secretory organelles, termed as micronemes (Canning and Sinden, 1973). Also, the 
successful ookinete maturation requires de novo protein synthesis and transfer via the 
micronemes. The transcripts of these proteins are not only ookinete specifically produced but 
also formerly translationally repressed, during the female gametocyte stage, as defined by gene 
deletion studies (Hall et al., 2005; Ekcer et al., 2008). Together these processes of ookinete 
maturation facilitate the motility and invasive ability required for the ookinete to escape the 
tightly packed blood bolus and traverse the midgut epithelium. 
The mechanism that regulates the post-translational repression in female gametocytes of 
gene products essential for zygote formation and development, involves a DDX6-class RNA 
helicase named development of zygote inhibited (DOZI). The best characterised example is that 
of the Plasmodium surface proteins P28/25, between 368 other gene products (examined in P. 
berghei). DOZI co-localises with translationally repressed p25 and p28 transcripts, in 
cytoplasmic bodies in the female P. berghei gametocyte (Mair et al., 2006; Khan et al., 2005).  
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1.3.2.4 Midgut invasion 
 
After maturation, the ookinete invades the midgut epithelium in order to reach the basal side of 
it, where the oocyst will be formed.  This requires contractile, twisting and gliding motility of the 
ookinete and secretion of penetration mediating and protective proteins. Universally, the 
Plasmodium motility and invasion machinery is dependent on apical discharge of secretory 
vesicles. 
In the beginning of the invasion, the ookinete crosses the chitinaceous peritrophic matrix, 
which covers the inner (apical) face of the midgut epithelium, a process facilitated by the 
secretion of a chitinase (CHIT1) (Huber et al., 1991; Dessens et al., 2001). Additionally, in P. 
berghei, a calcium-dependent protein kinase, CDPK3, probably involved in ookinete motility, 
has an important contribution to the early events of midgut invasion (Ishino et al., 2006; Siden 
and Kiamos et al., 2006). 
The next barrier is the inner surface of the midgut epithelium, on which the ookinete 
attaches in order to penetrate the membrane and enter the lumen of more than one the epithelial 
cells in row (Vlachou et al. 2006). For this process, members of a conserved Plasmodium 
perforin like protein (PPLP) family are recruited. This family, characterised by a membrane-
attack complex and and perforin (MACPF)-related domain, consists of five members. Their 
secretion during invasion is supported by the localisation of PLP1 and PLP3 identified in the 
micronemes (Kadota et al., 2004; Kaiser et al., 2004) and their essentiality to cell penetration is 
indicated by gene deletion experiments of PPLP3 and PPLP5.  
Genes subject to DOZI-mediated translational repression are also known for their 
contribution to the invasion process. Three of these are the major Plasmodium ookinete surface 
proteins, P25 and P28 and von Willebrand factor A domain-related protein (WARP). Potentially 
mediating in intercellular interactions (encoding epidermal growth factor (EGF) domains), 
P25/28 proteins have been postulated to play a role both protective against proteases and 
essential to the development of ookinete and invasion (Tomas et al., 2001), while WARP 
localises in the micronemes only of mature ookinetes (Yuda et al., 2001).  
Other (potentially) secreted proteins implicated in traversal of the midgut barrier are the 
secreted ookinete adhesive protein (SOAP) (Dessens et al., 2003) and putative secreted ookinete 
proteins (PSOPs), identified in P. berghei (Hall et al., 2005; Ecker et al., 2008).  
 
 
1.3.2.5 Ookinete-to-oocyst transition 
 
When the ookinete exits the midgut epithelial cell towards the basal side of the midgut, it 
confronts the hemolymph and the basal lamina. Interestingly, it has been proposed that this 
contact with the basal lamina induces the ookinete to oocyst transformation, without having 
elucidated the true role of it. This hypothesis was initially based on the observation that 
ookinetes injected into the mosquito haemocoel can transform into oocysts on the basal lamina 
of the malpighian tubules and the fat body, apart from that of the midgut (Weathersby, 1954).  
Also, studies showing that KD of mosquito laminin-γ1 (LANB2), a basic component of 
basal lamina, results in a reduction in oocyst numbers support this theory (Arrighi et al., 2005). 
Additionally, it has been observed that P25 and P28 (Vlachou et al., 2001), the circumsporozoite 
and TRAP-related protein (CTRP) (Mahairaki et al., 2005), and SOAP (Dessens et al., 2003) 
bind mosquito laminin, assigning to these proteins a crucial participation in the developmental 
transition between ookinete and oocyst, apart to that in mediating invasion. 
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After ookinete is immobilised contacting the basal lamina, it begins the morphological 
transformation to round-shaped oocyst, by losing the subpellicular microtubules, apical complex 
and double-membrane pellicule but maintaining the tetraploid genome (Canning and Sinden, 
1973). Finally, the apical and the posterior protrusion are absorbed and a single-membrane 
plasmalemma coats the new-born oocyst (Carter et al., 2007). A P. berghei nuclear formin-like 
protein, named MISFIT, is the first discovered protein with paternal effect on the development of 
the parasite. PbMISFIT is expressed in male gametocytes and localises to the nuclei of 
microgametes, zygotes and ookinetes. Gene deletion experiments have demonstrated that 
PbMISFIT has an essential male-inherited role in ookinete-to-oocyst transformation and that 
absence of expression leads to transmission blockade (Bushell et al., 2009). 
 
 
1.3.2.6 Oocyst maturation and sporogony 
 
During the development of the oocyst a proteinaceous capsule gradually surrounds the 
plasmalemma while the genome undergoes multiple rounds of replication (Sinden and Strong, 
1978). During karyokinesis, the polyploid genome is apportioned in the sporoblasts, 
compartments formed by the plasmalemma invagination. The nucleus and subcellular organelles 
are distributed into the sporozoites budding off from the sporoblasts, ultimately resulting in the 
formation of the mature oocyst which contains thousands of haploid sporozoites, characterised as 
sporulated (Sinden and Strong, 1978). This is the only stage in the life cycle in which the parasite 
replicates extracellularly. 
Despite the poor information about the molecular mechanisms regulating the oocyst 
maturation and sporogony, an essential for this process gene product has been characterised: the 
conserved among Plasmodia circumsporozoite protein (CSP). CSP is associated with the plasma 
membrane of both the maturing oocyst and the developing sporoblasts and becomes the main 
surface protein of oocyst and salivary gland sporozoites, through its glycosylphosphatidylinositol 
(GPI) anchor (Nagasawa et al., 1988). The essentiality of CSP in the sporogony is determined by 
csp gene deletion experiments in P. berghei revealing a cytokinesis blocking and impotence in 
sporozoite formation (Menard et al., 1997).  
Also, members of the limulus clotting factor C, Coch-5b2 and LglI (LCCL)–lectin 
adhesive-like protein (LAP) family (Dessens et al., 2004; Trueman et al., 2004)  are significantly 
involved in oocyst development and sporulation, as well as  PSOP13 (Ecker et al., 2008). 
Finally, a protein which is exclusively localised to the capsule of the developing oocyst, 
has been identified: CAP380. Absence of CAP380 results in gradual extermination of developing 
oocysts, suggesting a protective property of CAP380 during the maturation oocyst of the oocyst 
inside the immune-rich hostile environment (Srinivasan et al., 2008).  
 
 
1.3.2.7 Sporozoite motility and salivary gland invasion 
 
The next step of the parasite migration in the mosquito vector is the sporozoire egress 
from the oocyst and their journey to the salivary glands. The active process of sporozoite release 
is facilitated by the egression cysteine protease (ECP) (Aly and Matuschewski, 2005), which 
includes a region enriched in positively charged amino acids (Wang et al., 2005).  
The sporozoite migration towards the salivary glands is not yet fully illuminated, thus 
there is a controversy between chemotactic and passive transfer through the hemocoel 
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circulation. It is clear, though, that sporozoite, as ookinete, motility is an absolute requirement 
for overcoming the challenges of salivary gland invasion. 
 Sporozoite surface proteins, TRAP, CSP (Tewari et al., 2002) and transmembrane 
protein S6, which is subject to post-translational repression during former stages, (Steinbuechel 
and Matuschewski, 2009) are essential for sporozoite motility and salivary gland invasion. 
Intriguingly, trap gene family includes ctrp, which is expressed during midgut and salivary gland 
invasion, as well as merozoite trap homologue, the expression of which is important for 
erythrocyte invasion (Kappe et al., 2004), suggesting that facing similar barriers leads the 
parasite to recruit similar molecular mechanisms both in the vertebrate and the mosquito host 
(Vlachou et al., 2004).  
The force for Plasmodium gliding motility is generated by an actomyosin motor that is 
captured apically between the plasma membrane and the inner membrane complex (Kappe et al., 
2004), through aldolase by transmembrane receptors of the TRAP family (Schuler and 
Matuschewski, 2005). 
During the salivary gland invasion and in contrast to the midgut invasion, the sporozoite 
traverses the epithelium from the basal to the apical side, while homing in on the ducts of the 
glands, implying that not only similar but also different molecular mechanisms are inducing both 
invasions. A parasitophorous vacuole of host cell origin, absent during midgut invasion, is 
formed due to the interaction of the parasite with the basal plasmalemma, enveloping and 
feeding the parasite while leading it inside the epithelial cell (Pimenta et al., 1994). On the 
contrary, salivary gland and midgut peptide 1 (SM-1) inhibits both the midgut and the salivary 
gland invasion (Ghosh et al., 2001) at the initial binding and recognition of the epithelium, when 
merozoite apical erythrocyte-like protein (MAEBL) (Kariu et al., 2002) and CSP (Kappe et al., 
2004) are recruited.      
During the transfer to the secretory cavity of the glands, the parasite is coated by a second 
parasitophorous vacuole, which gradually disintegrates and releases the sporozoite. After egress, 
the sporozoites migrate to the ducts by glinding motility (Frischknecht, 2004), from where they 
are transmitted passively to a new vertebrate host via mosquito blood-feeding or remain in the 
secretory cavities for future transmission (Rodriguez and Hernandez-Hernandez Fde, 2004).  
 
 
Figure 1.8. Overview of the identified Plasmodium genes, expressed during its intravector development. 
Adapted from (Ahmed et al., 2009). 
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1.3.3 Vector response – the transmission bottleneck 
 
Plasmodium must complete a complex sexual development in the mosquito vector in 
order to achieve successful transmission to the vertebrate host. During its traverse through 
several mosquito tissue compartments, it encounters not only physical barriers but also host’s 
defence responses. Due to parasite’s impact on mosquito fitness, reproduction, and survival, 
mosquito’s innate immunity is activated (Hogg & Hurt, 1991; Ferguson & Read, 2002; Ahmed 
and Hurt, 2006). The outcome of the finely balanced agonistic and antagonistic mosquito-
parasite interactions developed during the parasite journey through the mosquito is either 
successful transmission, in Plasmodium susceptible Anopheles mosquitoes (with variant 
vectorial capacity) or destruction of the malaria parasite and transmission blockade, in refractory 
ones. 
Developments in genome-wide approaches, genomics and proteomics, have shed 
significant light on the biology of the Plasmodium parasite during the malaria transmission cycle 
in the vector and the Anopheles immune response. Studies about the mosquito-parasite molecular 
interplay and the mosquito immune system have mainly targeted the major human malaria 
vector, A. gambiae, and include infections with the rodent model Plasmodium berghei 
(Christophides et al., 2004). 
These studies have outstandingly proved that the parasite suffers substantial losses at 
different stages of the development inside the invertebrate host, due to mosquito factors that 
affect its development (Figure 1.9), not only in Plasmodium refractory but also in susceptible 
mosquitoes. Although the severest bottleneck of malaria transmission occurs during ookinete 
invasion of the midgut epithelium, the Anopheles defence reaction is not confined to this phase 
of the parasite migration. Antagonistic (and agonistic, as described earlier) interactions are also 
developed before midgut invasion in the midgut lumen, after the sporozoite release from the 
oocyst in the haemolymph and during the ivasion of the salivary glands (Vlachou et al., 2005).  
The first significant reduction in the number of parasites is observed in the mosquito 
midgut lumen, during the parasite gametogenesis (Christophides et al., 2004). Although the 
initial mosquito response which includes identification of the parasite, generates a favourable 
environment for the process of gametogenesis (XA, low pH, optimum temperature), 
nonappearance of exflagellation has been observed in some mosquito species, suggesting the 
potential presence of inhibitors or absence of activators (Vlachou et al., 2005). The second 
critical stage in the parasite development that encounters an encumbrance by yet unknown 
factors of the mosquito is fertilisation, followed by zygote maturation inside the midgut lumen. It 
is suggested that digestive enzymes, such as trypsins, assault the parasites playing a notable role 
in the reduction of their number (Muller et al., 1993). 
Another parasite limiting phase is observed after the release of sporozoites from the 
mature oocyst. The sporozoites must navigate the haemolymph which is enriched with abundant 
humoral and cellular immune factors that cause degradation of a respectable amount of 
sporozoites, in order to reach and invade the salivary glands. Thus, a rapid salivary gland 
invasion (>8 hours) is required in order to avoid the destruction by the mosquito immune 
reaction (Hillyer et al., 2007).   
 As outlined earlier, the most devastating for the parasite number stage is the invasion of 
the midgut, due to the extensive parasite-mosquito interactions that are developed. Based on this 
transmission bottleneck, several studies have examined targets potentially responsible for 
transmission blockade. Although the hypothesis that midgut invasion is receptor-mediated is not 
yet confirmed, it is shown that midgut expressed annexines which bind to the P. berghei 
invading ookinete are valuable to the process of invasion (Kotsyfakis et al., 2005).    
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 The mosquito responses triggered by the parasite invasion of the midgut involve, as 
obviously suspected, the activation of innate immune reactions (which are proved to be 
fundamental in refractoriness (Habtewold et al., 2008)), of which the major ones are parasite 
lysis and melanisation, and local epithelial responses.  
    The molecular identification of potential immune factors against invading ookinetes was 
achieved through Anopheles genome sequencing and experimental studies (Meister and Koutsos, 
2004; Christophides et al, 2004). The majority of the identified proteins that regulate the anti-
Plasmodium immune responses are detected in the haemolymph, nominating the crucial role of 
this open circulatory system in the systemic defence against the parasite.   
It is demonstrated that the obliteration of up to 80% of the P. berghei invading ookinetes 
is mediated by two A. gambiae gene products: thioester-containing protein 1 (TEP1), which is a 
complement-like protein, and leucine-rich repeat immune protein 1 (LRIM1). TEP1 and LRIM1 
are found to be involved both in lysis of Plasmodium ookinetes and phagocytocis of bacteria 
(Blandin et al., 2004; Osta & Christophides et al., 2004) and to interact together with APL1C (a 
member of LRIM family) as they circulate inside the haemolymph (Povelones et al., 2009; 
Povelones et al., 2011). 
A next barrier to the surviving ookinetes, raised by the mosquito immune system is 
melanisation, an important to arthropods humoral immune response (Cerenius et al., 2004). 
During this process, some ookinetes are destructed by toxic reactive oxygen intermediation or 
asphyxiation after being encased in melanine capsules. Melanine synthesis is catalised by active 
phenoloxidases (PO) which are generated by proteolytical cleavage of pro-phenoloxidases 
(PPO), a reaction regulated by an extracellular cascade of proteinases, including clip-domain 
serine proteases, inactive serine protease homologues that are missing catalytic triad residues, C-
type lectins (CTLs), and serpin inhibitors (SRPNs). Recently, the first inhibitory serpin-serine 
proteinase pair in mosquitoes was identified, in which A. gambiae proteinase CLIPB9 is 
inhibited by SRPN2 (An et al., 2011).  
Apart from the previous two main reactions, additional immune responses that assist the 
parasite killing before and during invasion have been indicated. Specifically, it is shown that 
antimicrobial peptides produced upon immune signalling mediate in the melanisation process 
(Meister et al., 2005). 
A significant barrier to the Plasmodium ookinete is posed not only by the immune 
response of the mosquito but also by local epithelial reactions, activated upon intracellular 
invasion of the midgut epithelium. Apoptosis and actin cytoskeleton and microtubule 
remodelling of the invaded cell are triggered, resulting in the formation of an actin-based 
structure, known as the parasite hood, which enfolds the ookinete during its exit from the 
midgut. The hypothesis that the parasite hood is part of the a local epithelial immune response is 
supported by its resemblance of a phagocytic cup formed during bacteria phagocytosis and the 
documented mediation of TEP1 and LRIM1, two major anti-parasitic factors, in bacterial 
phagocytosis. Also, enhancement of this theory derives from RNAi-dependent gene silencing 
experiments of Wiskott–Aldrich syndrome protein (WASP), an activator of actin nucleation, and 
Apolipophorin II/I (ApoII/I), two major factors in mosquito’s lipid transport. According to the 
obtained results, WASP is identified as an antagonist of parasite development while ApoII/I are 
involved in mosquito-egg development and ookinete survival (Vlachou et al., 2005b).   
It is also suggested that, as in microbial pathogen infection, cytoskeleton remodelling of 
the midgut epithelial cells during ookinete invasion could be a result of either indirect 
stimulation (apoptosis) or direct induction by Plasmodium molecules, such as Subtilisin 2, a 
serine protease Plasmodium secrets inside the epithelial cells and is observed to be associated 
with actin filaments (Han et al., 2000).  
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Two other mechanisms recruited by the invaded cells, probably against parasites, are the 
reported enhancement of nitric oxide synthetase (NOS) activity and peroxidase activity which 
induce degeneration of the invaded cell by tyrosine nitration (Kumar et al., 2004). This was 
further supported by recent studies which illustrated that epithelial peroxidase/NOX5 (HPX2 
peroxidase and NADPH oxidase 5) nitration and parasite lysis mediated by TEP1 are 
sequentially activated, pointing out a potential role of nitration to the mosquito complement 
activation against the parasites (Oliveira et al., 2012).  
The nadir of the Plasmodium population is observed during this severe mosquito-parasite 
battle stage, with the parasite numbers reducing down to 1-10% of the initial ones (Christophides 
et al., 2004). Due to this reason, this stage presents the strongest bottleneck effect, with a critical 
result in the success of the parasite transmission (Figure 1.9). After the invasion of the midgut 
epithelium and the burst of only one mature oocyst, though, the sporozoite numbers can reach 
again a respectable value and, therefore be transmitted, impeding sterile immunity (in susceptible 
mosquitoes). An insight of the interplay between the parasite and the mosquito genes that 
significantly affect the parasite development especially in the transmission bottleneck stage 
could proffer new prospects in the development of transmission blocking interventions (Vlachou 
et al., 2005; Sinden et al., 2007).  
  
 
 
 
Figure 1.9. Graphic representation of the Plasmodium population bottleneck during its developmental 
migration in the mosquito vector, with the nadir in number recorded at the oocyst stage. Source: 
http://kafatos.openwetware.org/Research.html 
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1.4 Control measures and impediments to eradication 
 
1.4.1 Mosquitoes 
 
The primary goal of vector control is to reduce the vectorial capacity of local vector populations 
below the critical threshold in order to prevent endemic or epidemic transmission. Vectorial 
capacity (also mentioned earlier) refers to the efficiency of the prevailing mosquito populations 
to transmit malaria. 
 
 
1.4.1.1 Limitation of the host-mosquito contact 
 
Due to the nocturnal feeding pattern of most 
Anopheles vector species, a simple but intertemporal 
protection against malaria has been developed, 
aiming at the reduction of the contact between 
mosquitoes and humans: mosquito bednets. The 
modern advanced betnets are constructed with 
insecticide treated nets (ITN), which are impregnated 
with pyrethroids, reducing the female mosquito 
survival due to contact with lethal insecticides (Curtis 
et al., 2006). Also, long-lasting insecticide-treated 
nets (LLINs) have been developed, maintaining 
effective insecticide levels for at least three years. It 
is demonstrated that the outcome of ITN use is a 
significant reduction in the malaria related morbidity and mortality (Takken, 2002).  
Although, in endemic areas socioeconomic factors have raised barriers to the efficient use 
of ITN (Guyatt and Snow, 2002), a problem that national malaria control programmes and their 
partners are trying to overcome by ITN/LLINs free contribution (Guyatt and Snow, 2002; WHO 
Global Malaria Programme: Position Statement on ITNs). Nevertheless, genetic based and 
behavioural pyrethroid resistance of mosquitoes, related to ITN use is also an upcoming issue.  
 
 
1.4.1.2 Destruction of vector mosquitoes and mosquito breeding sites (insecticidal and larvicidal 
methods) 
 
Reduction or elimination of mosquito populations can be achieved via chemical, 
biological or genetic approaches directed towards adult or larval stages. 
One of the most effective method that eradicated malaria in many temperate and tropical 
low-transmission regions was large scale indoor residual spraying (IRS) of insecticides. The 
principle of this method relies on the endophilic feeding pattern of many Anopheline females. 
After blood-feeding, the female mosquito rests on a nearby surface while digesting the blood-
meal and, thus, insecticide sprayed walls can be an effective lethal trap, reducing the number of 
infected vectors, capable of transmission (Bruce-Chwatt, 1987).  
The first and historically the most popular insecticide used for IRS is DDT, which in 
conjunction with chloroquine was the main control measure of WHO Global Malaria Eradication 
campaign launched in 1955. Although this large scale spraying eliminated malaria in many 
temperate and l temperate and tropical low-transmission areas (Sadasivaiah et al., 2007), it failed 
Figure 1.10. Insecticide treated mosquito net                     
protecting a sleepy child. 
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to totally eradicate malaria in high-transmission endemic regions. This is attributed to the main 
problem that DDT-based IRS campaign and all forms of IRS confront: the insecticide resistance 
via evolution of mosquitoes.  
Thus, the World Health Organization (WHO) currently advises the use of 12 different 
insecticides in IRS operations. These include small amounts of DDT and a series of alternative 
insecticides (such as the pyrethroids, deltamethrin and permethrin) to both, combat malaria in 
areas where mosquitoes are DDT-resistant, and to slow the evolution of resistance.  
Another approach, which could be used in combination with IRS, uses spores of the 
Beauveria bassiana, an entomopathogenic fungus which kills mosquitoes. There is experimental 
evidence that contact with the fungi could yield up to 80% reduction of mosquito numbers and 
that fungi-infected mosquitoes decrease blood feeding frequency, resulting in a reduction of 
mosquito bites (Scholte & Ng'habi et al. 2005; Blanford & Chan et al. 2005; Scholte & Knols et 
al. 2006). 
 Biological agents can also be used against larval stages, which were restrained by 
environmental engineering methods, before the introduction of DTT. For example, commonly 
used biological control agents for larval stages include larvivorous fish and Bacillus 
thuringiensis (Bt), with Bt being a highly used control agent in Europe and the Americas (Mittal 
2003).  
More recently introduced strategies include sterile insect technique (SIT), release of other 
genetically modified mosquitoes and paratransgenesis. SIT comprises the sterilization of male 
mosquitoes (via irradiation or genetic means) prior to their release, in order for their offspring 
with wild female to be sterile. This technique, though, has a restricted scale application, as it 
results in a low mating competence of sterile males.  
Several approaches have focused on the generation of genetically modified mosquitos 
which will cause suppression to the general mosquito population or replacement by malaria 
refractory strains. Genetically modified males the offspring of which is sexually restricted to 
male (Christophides, 2005), display robust refractoriness against Plasmodium or carry a 
dominant lethal gene (release of insects carrying a dominant lethal – RIDL) are already 
engineered, giving a boost to the promising application of these methods for malaria elimination.   
The paratransgenesis approach relies on the large number of naturally symbiotic with the 
mosquito bacteria, which, after genetic modification, could have a lethal effect towards the 
mosquito or even the Plasmodium parasite (Riehle, Moreira et al. 2007; Wang et al., 2012). 
 
 
1.4.2 Human (drugs/vaccines) 
 
1.4.2.1 Anti-malarial drugs 
 
Untreated malaria in a non-immune individual can readily progress within hours to life-
threatening illness, thus anti-malarial drugs have currently wide-spread application, targeting 
both to treatment and prevention of the disease. Most of the anti-malarial drugs target the 
erythrocytic stage of Plasmodium infection in order to alleviate malaria symptoms. Specifically 
they target on four subcellular organelles and biochemical pathways of the parasite: food vacuole 
(haem-detoxification), cytoplasm (folate synthesis), mitochondrion (electron transport chain) and 
the apicoplast (protein synthesis), (Greenwood et al., 2008). Apart from short-term prophylaxis 
and treatment of the acute blood stage infection, terminal prophylaxis from the dormant liver 
stage hypnozoites (P. vivax) is necessary.  
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Currently, the drugs that have the broader use against malaria are quinine and its 
synthetic alternates, antifolates and artemisin and its derivatives.  Quinine is a natural compound 
extracted from Cinchona tree, the anti-malarial effect of which concentrates on the mature 
trophozoites by inhibiting the parasite haem-detoxification process (food vacuole) (Egan, 2008; 
Hanscheid et al., 2007). On the other hand, artemisin, another natural compound extracted from 
Artemesia annua, displays efficacy against all sexual blood stages, by a mechanism yet unclear. 
Finally, the antifolates inhibit parasite nucleic acid synthesis by interfering with folate synthesis 
pathway (Hyde, 2007). 
In order to reduce the risk of treatment failure and the side-effects, combination therapy 
comprises the contemporary practice in treating cases of malaria. Although combination therapy 
provides a decrease of this risk, still, drug resistance developed by the Plasmodium parasites 
poses the main barrier against malaria elimination, despite the broad use of anti-malarial drugs, 
as well as deficiency in new drug prospects.  
 
 
1.4.2.2 Vaccine perspectives 
 
Malaria vaccines are an area of excessive research. However, despite many years of effort, there 
has no effective vaccine been introduced into clinical practice, yet. As the use of an effective 
vaccine remains an elusive goal for every national malaria control programme, a great number of 
leads are emerging, with three vaccine strategies (Matuschewski, 2006):  
1) Pre-erythrocytic, liver stage vaccines 
2) Erythrocytic, blood-stage vaccines 
3) Transmission blocking, mosquito stage 
 
 
Figure 1.11. Sites in the malaria life cycle that could be interrupted by vaccines. a) Pre-erythrocytic stage 
vaccines target the invasion of the Plasmodium sporozoite and/or the infected liver cell (clinically silent stage). 
b) Blood stage vaccines target the eythrocytic asexual parasite stages (symptomatic stage). c) Transmission 
blocking vaccines target Plasmodium’s development inside the Anopheles vector, and consequently, malaria 
transmission to human.  
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The observation that low numbers of sporozoites invade liver, due to the natural 
bottleneck caused by epidermal injection, has proposed the targeting of liver stage sporozoites as 
an appealing approach. Pre-erythrocytic (liver stage) vaccines are designed to prevent the entry 
of sporozoites into hepatocytes or destroy infected hepatocytes (figure 1.11), by evoking 
protective immune responses that do not normally develop in natural infection, thereby 
preventing clinical disease.  
This approach was initially applied in animal models of malaria by vaccination with 
radiation-attenuated sporozoites (Herrington et al., 1991; Hoffman et al., 2002) but the recent 
generation of genetically engineered, live attenuated sporozoites by a defined single gene knock-
out is considered to be a safer for further application method (Mueller et al., 2005; van Dijk et 
al., 2005). A more cost-effective prospect, compared to that of a whole organism vaccine, is the 
development of a potential sub-unit vaccine. The most developed and promising subunit-vaccine 
candidate, targeting the liver stages of Plasmodium development, is RTS,S. RTS,S aims at 
protection achieved by immunization with the CS protein (CSP) (Casares et al., 2010) and is 
currently being evaluated in a phase III trial in Africa (Crawley, 2010).   
Vaccines against the pathogenic asexual blood stages of Plasmodium parasites are 
designed with the aim of preventing clinical disease by destroying the merozoites (figure 1.11). 
Since protective semi-immunity to malaria is acquired after repeated Plasmodium infections, it 
may be possible to mimic and stimulate the acquisition of naturally acquired immunity by a 
vaccine (Crompton et al., 2010).   
However, relatively few blood-stage antigens are in clinical development as vaccines, so 
far (Crompton et al., 2010). These include erythrocyte-binding antigen–175 (EBA-175) (Sahly et 
al., 2010), serine-repeat antigen 5 (SERA5) (Horii et al., 2010), apical membrane antigen 1 
(AMA1) (Sagara et al., 2009), glutamate-rich protein (GLURP) (Essen et al., 2009; Hermsen et 
al., 2007) and merozoite surface protein 1 (MSP1) (Ogutu et al., 2009), MSP2 (Genton et al., 
2003), MSP3 (Essen et al., 2009; Druilhe et al., 2005), all of which are highly expressed on the 
surface of the merozoite. Unfortunately, phase II trials of the most advanced blood-stage 
candidates, AMA1 and MSP1, that were recently conducted did not represent efficacy in African 
children (Sagara et al., 2009; Ogutu et al., 2009). Extensive P. falciparum polymorphism 
variation in parasite surface proteins, means that generation of an efficient blood-stage vaccine 
against this species is much more challenging (Matuschewski, 2006). 
Transmission-blocking vaccines which target the intravector stages of Plasmodium 
development, preventing the parasites from infecting the mosquito vectors and thereafter the 
human hosts, are discussed in detail in the next section. 
If malaria is to be eradicated a broader range of small molecule therapeutics able to target 
various stages in Plasmodium’s life cycle are required. Thus, interest in the development of a 
multi-antigen, multistage vaccine, is now increasing (Butler, 2009). This approach will possibly 
offer better protection than do single-antigen vaccines, and avoid vaccine failure caused by 
genetic diversity in parasite populations (Saul et al., 2007) 
 
 
1.4.3 Impediments to eradication 
 
Overall, although malaria is in essence a both preventable and curable disease, its 
eradication has not yet been possible. Despite substantial advances in treatment and prevention 
over the past decade, malaria still threatens the lives of millions of children in tropical countries. 
Although there has been an unprecedented surge in political commitment and international 
funding for malaria control (Babaeekho et al,. 2009), over the past decade, there are still negative 
parameters that reduce the efficiency of current control methods in both host and vector.  
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Two major hurdles threaten progress towards elimination: the increasing resistance of 
both parasite and mosquito to the chemical repertoire available and the limited availability of 
effective control methods (Egan and Kaschula, 2007).  Specifically, drug treatment is continually 
undermined by the development of drug-resistant parasite strains and the insecticide resistance of 
the mosquito vector. (Engwerda and Good, 2008). Without the rapid engineer of effective 
prospects for treatment and prevention, that are able to circumvent resistance, malaria 
elimination will become increasingly intractable and eradication impossible. Furthermore, 
socioeconomic factors as well as and deficiency of essential facilities in endemic regions 
constitute part of the trammels of malaria elimination, setting the access to not only effective but 
also affordable treatment at community level as key challenge (Babaeekho et al,. 2009).  
The numerous complicating factors which induce the continuing loss of almost a million 
human lives annually, underline the urgent need of new potential in malaria control.  
 
 
 
1.5 Transmission blocking interventions 
 
1.5.1 Transmission blocking vaccines: an ideal public good 
 
Until recently, strategies for malaria vaccine development concentrated on the prevention 
or treatment of clinical disease. However, the considerable reduction in malaria burden reported 
in several endemic countries (WHO, World Malaria Report, 2012) and the goal of elimination 
and eradication propose that greater prominence should be given to the deployment of vaccines 
that interrupt transmission. 
Highly effective pre-erythrocytic (and erythrocytic) stage vaccines can, in principle, 
reduce infection prevalence in the human host, including both the asexual stages and the 
gametocytes. Such vaccines can proffer protection against malaria and, coinstantaneously, 
contribute to the reduction of malaria transmission (The malERA Consultative Group on 
Vaccines, 2011). Nevertheless, decreasing the number of gametocytes potentially ingested by 
Anophelines does not guarantee the blockade of transmission.  
 Due to these reasons, a developing strategy aimed at breaking the cycle of malaria 
transmission is that of Transmission Blocking Vaccines (TBV). In contrast to the other two types 
of vaccine approaches that principally focus on direct human protection, the primary goal of 
TBV is to prevent or substantially reduce mosquito infectivity (Perlmann and Troye-Blomberg, 
2002). The principle of TBV is the vaccination of individuals with mosquito-stage parasite 
proteins, immunising them in order to elicit antibodies that are subsequently taken up by the 
mosquito during a blood meal (Carter et al., 2000). The antibodies are designed so to bind 
parasite antigens within the mosquito midgut, where it is present extracellularly and in small 
numbers. Thereby, they assist parasite killing mediated by antibodies and/or complement, or 
alternatively, interrupt parasite protein function and, thus, development, consequently abolishing 
transmission (Saul, 2007).  
TBVs are not designed so to directly protect the vaccinated individual from contracting 
malaria, but instead to indirectly protect individuals in the vaccinated community (herd 
immunity) by reducing the number of infection carrying vectors and circulating parasite 
population (Dinglasan and Jacobs-Lorena, 2008).  
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1.5.2 Transmission blocking targets 
 
Research on transmission-blocking vaccines has traditionally targeted to P. falciparum 
and P. vivax surface antigens of mosquito stages (Carter, 2001). Specifically, there has been a 
large body of work focusing on four surface proteins exposed on gametes (pre-fertilisation) and 
ookinete surface proteins (post-fertilisation) (Saxena et al., 2007). 
A successful transmission blockade has been demonstrated by the development of 
antibodies against two P. falciparum gametocyte expressed proteins Pfs48/45 and Pfs230 
(present already within the vertebrate host). The parasite is killed upon entry into the midgut 
lumen when gametocyte activation occurs and, thereupon, the proteins are displayed on the 
gamete surface. Experiments with in vitro expressed Pfs48/45 antigen with the desirable 
conformation have resulted in successful animal immunogenicity with a transmission-reducing 
activity in the sera (Outchkourov et al., 2008; Chowdhury et al., 2009).  
Two other TBV candidate proteins, Pfs25 and Pfs28 are only expressed and exposed on 
the parasite surface following entry into the mosquito midgut and are not present within the 
vertebrate. The limited polymorphism of these proteins, derived by the absence of adaptive 
immune pressure of the human host, constitutes an advantage over the erythrocytic vaccines 
(Saxena et al., 2007). A phase I trial of the P. falciparum and P. vivax proteins Pfs25 and Pvs25, 
respectively, formulated with Montanide ISA 51, demonstrated mild adverse events and 
functional transmission blocking immunity against the two Plasmodium species (anti-Pfs25 and 
anti-Pvs25 IgG response) (Malkin et al., 2005; Wu et al., 2008). 
 
 
1.5.3 Transmission blocking vaccine strategies 
 
Although the approach seems reasonable and promising, transmission-blocking vaccine 
development and implement encounters some difficulties. A concern associated with TBV is that 
the antigens are never naturally expressed in the human host, resulting in absence of natural 
boosting with antibody responses being, usually, short-lived. An additional issue is that the 
proportion of the gametocyte carriers immunised in a local transmission area could limit the 
efficacy of the vaccine. As a result, vaccination should be applied en masse in order for the 
vaccinated cohort to develop a robust immune response in order to achieve adequate 
transmission blocking levels (Saul, 2007; Carter, 2001). Finally, it may be difficult to widely 
implement a vaccine that has no direct benefit to the individual but, instead, offers protection to 
the vaccinated community (Crompton et al., 2010). 
Nevertheless, several advantages of TBVs over pre- and erythrocytic vaccines have 
established a campaign towards their development. Since TBV mediated parasite killing is well 
defined (antibody or antibody and complement mediated killing), the efficacy of TBVs can be 
easily assayed ex vivo by membrane feeding upon gametocytes in the presence of immunised 
sera, without putting vaccinated individuals in the risk of infection. The localised nature of 
malaria transmission and the limited dispersal range of the mosquito vectors, within a few 
hundred to one or two kilometres, provide the advantage that vaccination of a relative small, 
localised group would cause a significant decrease in local transmission rates. Also, due to 
TBVs’ attribute of preventing the escape of the parasites from the human host, if used in 
combination with pre-erythrocytic and blood stage vaccines, they could serve to obviate or 
reduce the spread of parasites with resistance developed against such vaccines and, thereby, 
prolong the effective lifespan of other malaria vaccines (Carter, 2001). 
Under low endemic transmission conditions, a TBV program alone may be enough to 
eliminate malaria transmission within a locality. In high endemic areas, TBVs could make 
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eradication feasible with the concomitant implement of other interventions. The combination of a 
pre-erythrocytic and / or blood stage vaccine to prevent infection with a TBV would be an ideal 
vaccine strategy because it would reduce more effectively the rates of transmission and offer 
protection to vaccinated individuals (Carter, 2001). The establishment of a multi-target and 
multi-stage vaccine would relegate the low appeal to endemic communities arising from its 
altruistic concept (Saul, 2007). 
Despite the theoretical problems cited above, and based on its promise for malaria 
elimination, preclinical and clinical development of transmission-blocking vaccines is underway. 
Thus, many more gametocyte or ookinete proteins are under investigation for their transmission 
blocking potential, currently (Pradel, 2007). In addition, mosquito proteins could be potential 
targets to raise transmission blocking antibodies, such as proteins directly binding to the parasite 
surface and mediate parasite killing, or alternatively, essential parasite-interaction partners that 
promote parasite development (Dinglasan and Jacobs-Lorena, 2008). The historical success of 
vector control underlines the importance of studying transmission and vector-host interactions in 
order to support the deployment of efficient malaria control methods. 
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CHAPTER 2: AIM OF THE PROJECT 
 
As described previously, malaria is still a scourge for under-developed countries. 
Nevertheless, the understanding of the molecular processes during the parasite life cycle in both 
hosts increases. Consequently, there are promising perspectives of advances in the endeavour to 
the disease eradication. 
The aim of this diploma project was to identify novel, sexually expressed Plasmodium 
falciparum genes that could regulate the parasite transmission. Genes of special concern were the 
ones indicating that play a significant role in interactions between the parasite and the vector or 
regulate the parasite development, during midgut invasion and ookinete-to-oocyst transition, 
when parasites encounter severe reduction in their numbers.  
The project strategy consists of candidate gene selection mainly through the analysis of 
microarray transcriptional profiling, followed by functional characterisation of transgenic P. 
berghei parasites generated by targeted gene disruption (P. falciparum orthologs). The long-term 
goal of the project is the deepest understanding of the parasite behaviour during the mosquito 
midgut invasion and, hopefully, the identification of novel parasite targets for the generation of 
transmission blocking interventions. 
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CHAPTER 3: MATERIALS AND METHODS 
 
3.1 Parasite strains, maintenance and manipulation  
 
3.1.1 Parasite strains 
 
For the generation of gene KO parasites by double homologous recombination, the 
parasite strain that was used was P. berghei ANKA clone 507 (referred to as Pbc507), (Janse et 
al., 2006a). The Pbc507 is a transgenic parasite line in which the expression of enhanced Green 
Fluorescent Protein (eGFP) is under control of native elongation factor-α loci promoter, resulting 
in constitutive expression of eGFP throughout the parasite lifecycle (Franke-Fayard et al., 2004). 
The 507 clone has no drug resistance marker (Janse et al., 2006a). This absence of resistance 
becomes an advantage in the selection of subsequent gene KO parasites by the use of the 
established tgdhfr-ts pyrimethamine selection system. As a consequence, it assists the phenotypic 
analysis of the generated transgenic parasite in a GFP background.  
Genomic DNA from the P. berghei ANKA 2.34 (Wild-type, WT) clone was used for 
amplification of the upstream and downstream regions of target-genes and total RNA (converted 
to cDNA) from the same clone was used as template for RT-PCR.   
 
 
3.1.2 Parasite maintenance 
 
P. berghei parasites were maintained in Theiler’s Original mice (TO) (Harlan, UK) as 
previously described (Sinden et al., 2002). 
Intraperitoneal (IP) injection of 100-200 μL P. berghei infected blood was conducted for 
mice infection. Before transfection, reticulocyte proliferation was stimulated by IP injection of 
phenylhydrazinium HCl (PH); (6 mg/mL stock (Sigma) solution in Phosphate Buffer Saline 
(PBS); 10X stock solution of 0.2 M phosphate, 1.5 M NaCl, pH 7.4), in order for high 
parasitaemia / gametocytaemia to be induced.  
P. berghei infected blood for passage, cryopreservation or experimental use was collected 
by cardiac puncture (using an 1ml syringe containing 0.05ml heparin (200 I.U./ml), Sigma), on 
mice under terminal anaesthesia (intramuscular injection (IM) of 0.05mL / 10g body weight of 
Rompun (2% stock solution, Bayer), Ketastet (100 mg / mL ketamine, Fort Dodge Animal 
Health Ltd.) and Phosphate Buffer Saline (PBS, Sigma) prepared to a ratio of 1:2:3), on day 3-4 
of infection. 
The course of parasitaemia was determined in Giemsa (Fluka) stained thin tail-blood 
smears, by counting the blood stage parasites at 100X magnification on a light microscope. The 
tail-blood films were air-dried, methanol fixed and Giemsa stained (1:5 dilution in Giemsa buffer 
(0.7% (w/v) anhydrous KH2PO4, 1% (w/v) anhydrous Na2HPO4)) for 20 min at room 
temperature.  
All animal procedures were performed according to UK Home Office project license 
agreements by Valerie Chiamaka Ukekbu and Katarzyna Sala. 
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Cryopreservation 
Parasite stocks were prepared at 1:2 ratio of infected heart-blood to freezing solution 
(90% v/v Alsever’s solution (Sigma) and 10% v/v glycerol) and maintained at -80ºC. The stocks 
were thawed in room temperature, before immediate IP injection to mice. 
 
 
3.1.3 Purification of mixed blood-stage parasites 
 
Mixed blood-stage parasites were purified through lysis of red blood cells using ice-cold 
0.17M NH4Cl (Sigma), followed by centrifugation at 200 g for 10 min. Parasite harvest was 
subsequently pelleted by 10 min centrifugation at 1500 g, supernatant removed and pellet 
washed in PBS. 
 
 
3.1.4 Schizont cultivation 
 
Blood was obtained from three anaesthetised mice infected with P. berghei ANKA clone 
507 on day 1-2 of infection (parasitaemia ~5%), providing the blood-stage parasites for the 
transfections. The blood was immediately transferred to a tissue culture flask containing 100 mL 
of 75% (v/v) schizont culture medium RPMI1640 pH 7.3 (RPMI1640 with 25 mM HEPES, 2 
mM L-glutamine,  24 mΜ  NaHCO3 (Gibco)), 25% (v/v) foetal bovine/calf serum (FBS/FCS, 
Gibco) and 50 U / mL penicillin, 50 μg / mL streptomycin (PenStrep; Gibco). Then, the culture 
was gassed with CO2 for 5 min and incubated overnight shaking gently (50-100 rpm) at 37°C.  
 
 
3.1.5 Purification of viable schizonts 
 
Overnight schizont culture was poured into 50 ml Falcon tubes and pelleted 15 min 180 g 
at room temperature. After removal of the majority of the supernatant, the pellet was 
resuspended in remaining supernatant and layered on top of a 15.2% (v/v) Nycodenz / PBS 
density gradient. Schizont-infected cells were separated from uninfected cells by 15.2% (v/v) 
Nycodenz / PBS density gradient centrifugation (30 min at 300 g). The resulting thin ‘brown’ 
layer including the mature schizonts and localizing at the interface between the two suspensions 
was collected, washed in 30 mL Schizont medium, pelleted at 300 g for 8 min and supernatant 
was discarded. 
 
 
3.1.6 Ookinete in vitro cultivation 
 
0.6-0.8 mL of infected mouse blood was collected from mice under terminal anaesthesia 
with a parasitaemia of >10 %. The blood was immediately transferred to a tissue culture flask 
containing 30 mL 80% (v/v) ookinete culture medium (RPMI1640 (Sigma), 25 mM Hepes 
(Gibco), 2 mM L-glutamine (Sigma), 0.2% (w/v) sodium bicarbonate (Sigma), 50 U / mL 
penicillin, 0.05 mg / mL streptomycin (PenStrep; Gibco), 50 mg / 77 mL hypoxanthine (Sigma), 
100 μM xantheuric acid (pH 7.4, Aldridge) and 20% (v/v) FCS. Cultures were incubated at 19ºC 
for 24 hours for mature ookinete production. 
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3.2 Mosquito strains, maintenance, infections and tissue dissections 
 
3.2.1 Mosquito strains and maintenance 
 
A. gambiae N’gousho and Anopheles stephensi sda500 strains were cultivated according 
to standard methods (Sinden, 1997) and were reared and supplied by Tibebu Habtewold and 
Katarzyna Sala.  
 
 
3.2.2 Mosquito infections  
 
Blood feeding of mosquitoes on infected mice ensures natural infection. 3-7days post-
emergence A. gambiae or A. stephensi females were infected with P. berghei after 3 hour or 
overnight starvation, respectively. Mosquitoes fed on anaesthetised mice with a parasitaemia of 
2-10% and conspicuous gametocytaemia, while mice were mounted directly on the net-covered 
mosquito pots in the dark at 19ºC. After feeding was completed, mice were subjected to 
euthanasia by cervical dislocation while still sedated. Unfed females were removed 24 hours 
after the blood meal so to not interfere with the quality of infection and fed mosquitoes were 
maintained for 21-22 days p.i. feeding on solubilised fructose in in 19ºC, 70% humidity and 12 
hours daylight cycle.  
 
 
3.2.3 Mosquito midgut and salivary glands dissections 
 
In order study the biology of mosquitoes and their responses to microorganisms, 
including the malaria parasites, it is required that the various tissues are dissected and examined 
in isolation. 
Mosquito midguts were dissected in PBS under a dissection microscope, using dissecting 
forceps. The lower abdominal part of the mosquito was grasped and gently removed to reveal the 
midgut and separate it from malpighian tubules and foregut.  
Salivary glands were dissected in the same conditions, by gently grasping the mosquito 
neck and carefully separating the head from the thorax. The salivary glands were eventually 
separated from the head. 
 
 
3.3 Bacterial cultures 
 
 Bacterial culture aims at the massive production of genetically identical bacterial cells – 
clones, which thereafter will be used in specific biotechnological or molecular techniques. The 
provision of all the nutritional requirements of the cells is essential for the bacterial growth. The 
culture medium chosen for the culture must provide with carbon, nitrogen source, amino acids 
and several metal ions. Depending on the bacterial features and requirements, various time 
periods are appropriate for their growth and, also, different physical conditions, such as 
temperature, pH and oxygen, are required. Usually, the culture medium contains antibiotic in 
order to assist to the selection of the desirable clone. 
The desired bacteria cells were plated onto Luria Broth (LB) agar (Merck) plates, 
including 50 μg/mL of appropriate antibiotic, under aseptic conditions (using a Bunsen burner). 
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A disposable inoculating loop was used for the bacteria spreading onto the petri dish. The plates 
were incubated at 37ºC overnight. Single colonies were collected and transferred in liquid LB 
medium (Merck) for overnight growth.  
 
 
3.4 Nucleic acid isolation  
 
3.4.1 Purification of mixed blood-stage parasites and parasite DNA extraction 
 
P. berghei genomic DNA was extracted from infected RBCs, using Qiagen DNeasy 
Blood & Tissue Kit (Qiagen), following purification of RBCs from infected mouse blood. More 
specifically, ~200 μL of mouse blood collected by cardiac puncture were incubated in ice-cold 
20 mL 1% RBC lysis buffer for 30 min. Parasites were subsequently pelleted by 10 min 
centrifugation at 200 g, supernatant removed and pellet washed in 200 μL PBS twice 
(centrifugation of 1 min at 13000 rpm). After washing, pelleted parasites were resuspended in 
200 μL PBS and the protocol of Qiagen DNeasy Blood & Tissue Kit was followed. Briefly, 20 
μL proteinase K and 200 µl Buffer AL (without added ethanol) was added and the sample was 
vortexed and incubated at 56°C for 10 min, prior to 200 µL ethanol (96–100%) adding and 
mixing by vortexing. Afterwards, the mixture was pipeted in 3 into the DNeasy Mini spin 
column placed in a 2 ml collection tube and centrifuged at 8000 rpm. The DNeasy Mini spin 
column was placed in a new 2 ml collection tube (flow-through and collection tube were 
discarded) and 500 µL Buffer AW1 were added and centrifuged for 1 min at 8000 rpm. The 
DNeasy Mini spin column was placed in a new 2 ml collection tube (flow-through and collection 
tube were discarded), and 500 µl Buffer AW2 were added and centrifuged for 3 min at 14.000 
rpm to dry the DNeasy membrane. The flow-through and collection tube were discarded once 
again and the DNeasy Mini spin column was placed in a clean 1.5 mL microcentrifuge tube, 50 
µL Buffer AE were added directly onto the DNeasy membrane and incubated at room 
temperature for 1 min. A final centrifugation for 1 min at 8000 rpm was conducted to elute the 
parasite genomic DNA. 
 
 
3.4.2 E. coli plasmid DNA extraction 
 
Plasmid DNA was purified from the overnight cultures using the QIAprep Spin Miniprep 
Kit (Qiagen) or the HiSpeed Plasmid Midi Kit (Qiagen), depending on the volume of the 
cultures, after centrifugation of the overnight cultures for 10 min at 3000 rpm. 
 
 
3.4.2.1 QIAprep Spin Miniprep Kit Protocol using a microcentrifuge 
 
Pelleted bacterial cells were resuspened in 250 μL Buffer P1, including RNase A, prior to 
250 μL Buffer P2 adding and gentle mixing. This lysis reaction was incubated for 5 min at room 
temperature and, thereafter, 300 μL Buffer N3 were added and gently mixed. After 
centrifugation for 10 min at 13000 rpm the supernatant was transferred onto a QIAprep spin 
column for a second centrifugation for 1 min at 13000 rpm. The flow through was discarded and 
the column was washed by adding 750 μL Buffer PE, including ethanol. After disposal of the 
flow-through and an additional centrifugation for 1 min, elution of the plasmid DNA using 50 μL 
Buffer EB or dΗ2Ο, at 13000 rpm was perfomed. 
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3.4.2.2 Qiagen HiSpeed Plasmid Midi Kit Protocol 
 
Pelleted bacterial cells are resuspended in 6 ml Buffer P1, including RNase A, and 6 ml 
Buffer P2 are added and mixed thoroughly. After 5 min incubation at room temperature, 6 ml 
chilled Buffer P3 were added to the lysate and the sample was immediately and thoroughly 
mixed and poured into the barrel of a QIAfilter Cartridge. During 10 min incubation at room 
temperature, a HiSpeed Midi Tip was equilibrated by applying 4 ml Buffer QBT and allowing 
the column to empty by gravity flow. The QIAfilter outlet nozzle cap was removed and the 
plunger was inserted gently into the QIAfilter Midi Cartridge, in order for the cell lysate to be 
filtered into the previously equilibrated HiSpeed Tip. The cleared lysate was allowed to enter the 
resin by gravity flow. The HiSpeed Midi Tip was, subsequently, washed with 20 mL Buffer QC 
by gravity flow. DNA was eluted with 5 ml Buffer QF and, thereafter, precipitated by 5 min 
incubation with 3.5 mL room-temperature isopropanol. During the incubation the plunger from a 
20 ml syringe was removed and the QIAprecipitator Midi Module was attached gently onto the 
outlet nozzle. The eluate/isopropanol mixture was transferred into the 20 ml syringe and filtered 
through the QIAprecipitator using the plunger, to a waste container. The QIAprecipitator and, 
then, the plunger were removed from the 20 ml syringe in order for the DNA to be washed with 
2 ml 70% ethanol, following the same procedure as before. After two quick and forceful dryings 
of the membrane, the QIAprecipitator, was attached onto the outlet nozzle of a new 5 ml syringe 
and 500 μL of Buffer TE or dΗ2Ο were used for the elution of the DNA through the membrane.  
 
 
3.5 Nucleic acid manipulations 
 
3.5.1 PCR purification  
 
PCR products were purified using the QiaQuick PCR purification kit (Qiagen). Briefly, 5 
volumes of Buffer PB to 1 volume of the PCR sample were added and mixed. The sample was 
applied onto a QIAquick spin column, in a 2 ml collection tube and centrifuged for 1 min at 
13000 rpm. After the flow through discarding, the column was washed with 0.75 mL Buffer PE 
and dried at maximum speed. Finally, elution of DNA was ed using 30 μL Buffer EB (10 mM 
Tris·Cl, pH 8.5) or dΗ2Ο by centrifugation for 1 min at 13000 rpm.  
 
 
3.5.2 Ethanol precipitation of DNA (J. Sambrook, 2001) 
 
1/10 volume of sodium acetate, pH 5.2, (final concentration of 0.3 M) and 2 volumes of 
cold 100% ethanol were added to the DNA sample. The sample was mixed well and incubated 
for 30 min on ice. Thereafter, the sample was centrifuged for 20 min at 14000 rpm and 4ºC and 
the supernatant was discarded. 400 μL ethanol 70% was added, the sample was centrifuged once 
more for 10 min at 14000 rpm and 4ºC and the supernatant was decanted carefully. The pellet 
was air dried and resuspended in the appropriate volume of dΗ2Ο.    
 
 
3.5.3 Photometric assessment of DNA concentration 
 
Photometric assessment of nucleic acid concentration relies on the absorbance 
measurements made on a spectrophotometer. These measurements include the absorbance of all 
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molecules in the sample that absorb at the wavelength of interest. Since nucleic acids absorb at 
260 nm, they will contribute to the total absorbance of the sample. The ratio of absorbance at 260 
nm and 280 nm is used to assess the purity of DNA and RNA. A ratio of ~1.8 – 2.0 is generally 
accepted as “pure” for DNA and RNA. If the ratio is appreciably lower in either case, it may 
indicate the presence of protein, phenol or other contaminants that absorb strongly at or near 280 
nm. 
The concentration of DNA samples was determined in 1μL sample volume using the 
nucleic acid application of NanoDrop® ND-1000 Spectrophotometer (Thermo Scientific). 
 
 
3.5.4 Standard agarose gel electrophoresis 
 
 Agarose gel electrophoresis is an easy and fast method for 
separation and visualisation of nucleic acid fragments, depending on 
their size. The principle of this method is based on the phenomenon of 
the migration of charged molecules into a field with an electric current 
towards the opposite charge. The phosphate molecules which compose 
the backbone of DNA molecules have a high negative charge. When 
DNA is placed on a field with an electric current, these negatively 
charged DNA molecules migrate towards the positive end of the field, 
which in this case is an agarose gel immersed in a buffer bath. The 
agarose gel is a cross-linked matrix which assists as a three-dimensional 
mesh causing a sieving action which allows separations of molecules 
based on molecular size. Shorter molecules move faster and migrate 
farther than longer ones because shorter molecules migrate more easily 
through the pores of the agarose gel. DNA is visualised in the gel by 
addition of special for DNA visualisation stains such as ethidium 
bromide. These stains bind strongly to DNA by intercalating between 
the bases and absorb UV light causing DNA fluorescence (Kakani, 2009).  
DNA quality was assessed by standard agarose gel electrophoresis (J. Sambrook, 2001). 
1% Agarose gel was prepared using a Tris / Borate / EDTA (TBE) buffer and 1X (final 
concentration) SYBR Safe DNA Gel Stain (Invitrogen), for DNA visualisation, and the ladder 
used for product length verification was 1 Kb Plus DNA ladder (Invitrogen) (Figure 3.1). For 
loading and tracking of DNA samples in the agarose gel, GelPilot DNA Loading Dye, 5X 
(Qiagen) was used. 
 
 
3.5.5 Restriction digests 
 
The natural role of restriction enzymes is to protect bacterial cells from invasion by 
foreign DNAs, especially infections by viruses. This is achieved by cutting double stranded 
DNA at specific 4 to 8 base pair inverted repeat recognition sequences within the target DNA. 
DNA cleavage by restriction enzymes yields 5’-phosphate and 3’-hydroxyl termini and the 
products are either blunt ended or contain 5’ or 3’ overhangs, depending on the restriction 
enzyme type.  
In a 1.5 mL tube DNA, the appropriate buffer, BSA (if recommended by manufacturer), 
dH2O up to total volume and, finally, the restriction enzyme(s) were added. Specifically, the 
final concentration of the reagents was 1X Buffer, 1X BSA, 5 units/μL enzyme and maximum 10 
Figure 3.1. 1 Kb Plus 
DNA Ladder (Invitrogen) 
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μg DNA. The sample was incubated at the appropriate temperature (25ºC or 37ºC depending on 
the restriction enzyme) for at least 1 hour. 
 
 
3.5.6 DNA gel extraction   
 
After electrophoresis, QIAquick Gel Extraction Kit (Qiagen) was used for the extraction 
of the desirable DNA molecules. Briefly, the desired gel piece was extracted using X-Tracta™ 
gel extraction tool and transferred into a 1.5 ml tube where 500 μL Buffer GQ was added and the 
sample was incubated at 50ºC for 5-10 min. The resulting mixture was applied to a column and 
centrifuged and the flow-through was discarded. The column was washed with 750 μL Buffer PE 
and dried by centrifugation. Finally, 30 μL Buffer EB was used for the elution of the DNA. 
 
 
3.6 Plasmid cloning 
 
Plasmids are circular, double-stranded DNA (dsDNA) molecules that are separate from a 
cell’s chromosomal DNA. These extrachromosomal DNAs, which occur naturally in bacteria, 
yeast, and some higher eukaryotic cells, exist in a parasitic or symbiotic relationship with their 
host cell. The plasmids most commonly used in recombinant DNA technology replicate in E. 
coli. Generally, these plasmids have been engineered to optimise their use as vectors in DNA 
cloning. For instance, to simplify working with plasmids, their length is reduced; many plasmid 
vectors are only ≈3kb in length, which is much shorter than in naturally occurring E. coli 
plasmids. Most plasmid vectors contain little more than the essential nucleotide sequences 
required for their use in DNA cloning: a replication origin, a drug-resistance gene, and a region 
in which exogenous DNA fragments can be inserted (polylinker) (Lodish et al., 2000). 
 
 
3.6.1 PCR-vector selection 
 
Selection of the proper PCR-vector is based on the endings of the PCR product. More 
specifically, proof-reading polymerase creates blunt-ended PCR products in contrast to the 
products produced by Taq polymerase which have A (adenine) overhangs at their 3' ends. 
Therefore, blunt-ended PCR products can be ligated to linearised blunt-vector and Taq products 
can be ligated to linearised T-vector (carrying T overhangs at the 3' ends).   
Herculase II Fusion (Agilent) PCR products, which are blunt-ended, were ligated to pCR-
Blunt II-TOPO (Invitrogen) vector and GoTaq Green polymerase (Promega) products were 
ligated to pCR II-TOPO TA vector (Invitrogen).  
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Figure 3.2. Maps of PCR-vectors used for plasmid cloning, indicating their components (drug resistance 
genes, ORI etc.) and highlighting the restriction sites. 
Left map: pCR-Blunt II-TOPO vector (Invitrogen) used in ligation with blunt PCR products.    
Right map: pCR II-TOPO TA vector (Invitrogen) used in ligation with Taq PCR products. 
 
 
3.6.2 Ligations 
 
The PCR products were cloned to the appropriate PCR-vectors by following the 
instructions of Zero Blunt PCR Cloning Kit (Invitrogen) or TOPO TA Cloning Kit (Invitrogen). 
 
 
3.6.2.1 Zero Blunt PCR Cloning Kit protocol 
 
5 μL of concentrated blunt PCR product were mixed with 1 μL pCR-Blunt II-TOPO 
vector (25 ng), 1 μL 10X Ligation Buffer (with ATP), 2 μL dH2O (for a total volume of 9 μL) 
and, in the end, 1 μL T4 DNA Ligase (4 U/µL). The ligation reaction was incubated at 16°C for 
1 hour and, then, ended on ice. 
 
 
3.6.2.2 TOPO TA Cloning Kit protocol 
 
4 μL of concentrated Taq PCR product were mixed with 1 μL pCR II-TOPO TA vector 
(10 ng), 1 μL salt solution (final volume 6 μL) and the ligation reaction was incubated for 5 min 
at room temperature (22–25°C). 
 
 
3.6.3 Transformations 
 
The transformation method which was followed was chemical transformation of DH5α 
Escherichia coli (Invitrogen) competent cells. Specifically, the vectors were transformed into 
DH5α cells, having kanamycin resistance, by heat shock methodology. Briefly, 50 μL of 
chemically competent DH5α cells were thawed on ice and 5 μL of the plasmid DNA were added. 
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The sample was incubated on ice for 30 min. The cells were heat shocked for 20 seconds in a 
42°C water bath without shaking and, then, immediately placed on ice for 2 minutes. 250 μL 
S.O.C. medium (Invitrogen) were added to the cells and an incubation for 1 hour at 37°C and 
225 rpm followed. Subsequently, the cells were plated onto 50 μg/mL kanamycin (Sigma) Luria 
Broth (LB) agar (Merck) plates and the plates were incubated at 37ºC overnight. 
 
 
3.6.4 Identification of recombinant clones 
 
The phenomenon of transformation permits plasmid vectors to be introduced into and 
expressed by E. coli cells. In order to be useful in DNA cloning, however, a plasmid vector must 
contain a selectable gene, most commonly a drug-resistance gene encoding an enzyme that 
inactivates a specific antibiotic. When the treated cells are plated on a petri dish of nutrient agar 
containing the antibiotic, only the rare transformed cells containing the antibiotic-resistance gene 
on the plasmid vector will survive. All the plasmids in such a colony of selected transformed 
cells are descended from the single plasmid taken up by the cell that established the colony. 
The identification of transformed clones was assessed by the use of LB agar containing 
the antibiotic kanamycin (Sigma) 50 μg/mL.   
 
 
3.7 Transfection vector cloning 
 
3.7.1 Transfection vector 
 
The plasmid vector used for parasite transfection was pBS/TgDHFR vector which 
contains:  
1) Two polylinker sites, in which the homology regions, digested by the appropriate restriction 
enzymes, can be inserted  
2) An antibiotic resistance marker (ampicillin resistance gene – AmpR) outside the 
replacement/marker cassette, assisting the selection of the transformed bacterial clones  
3) A 5’ UTR and a 3’ UTR inside the replacement/marker cassette 
4) A pyrimethamine resistance marker (T. gondii DHFR/TS gene) for the selection of the 
recombinant parasites.   
The Pbc507 parasite line has no drug resistance marker, as mentioned earlier. This 
absence of resistance provides the opportunity to select subsequent gene KO parasites by the use 
of a drug selection system included in the integration construct. This drug selection system is 
provided by the pBS/TgDHFR vector.  
DHFR/TS fusion gene encodes for the dihydrofolate reductase-thymidylate synthase, a 
bifunctional dimeric enzyme, essential for the proliferation and growth of bacteria, Plasmodia 
and normal and cancerous human cells. The role of dihydrofolate reductase is to regenerate folic 
acid into its reduced form tetrahydrofolate, and its inhibitors, such as pyrimethamine, have 
antibiotic, antimalarial and antineoplastic properties. 
DHFR/TS gene derived from drug-resistant Toxoplasma gondii comprises a mutated 
around the active site of DHFR domain, confering resistance to pyrimethamine. Introduction of 
this gene into pyrimethamine sensitive P. berghei parasites results in a significant increase in 
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pyrimethamine resistance that allows for a relatively simple in vivo selection of transformed 
parasites procedure. 
 
 
 
Figure 3.3. Map of pBS/TgDHFR vector indicating its components. The T. gondii DHFR/TS gene and the 
AmpR gene are highlighted in orange and green arrow, respectively and their length is shown in parenthesis. 
The restriction sites and enzymes and the primer sites and names are also illustrated. Also, the 5’UTR and the 
3’UTR are represented by green lines and their length is shown in parenthesis.  
 
 
3.7.2 Ligation 
 
The targeting sequences and linearised transfection vectors were ligated using Quick 
Ligation Kit (New England Biolabs). Briefly, ~100 ng vector was combined with a 5-fold molar 
excess of insert and 10 μL 2X Quick Ligation Buffer, dH2O to 19 μL final volume and, finally, 1 
μL Quick T4 DNA Ligase were added. The ligation reaction was mixed thoroughly and 
incubated for 5 min at room temperature (22–25°C). 
 
 
3.7.3 Transformation 
 
The transformation method which was followed was chemical transformation of DH5α 
Escherichia coli (Invitrogen) competent cells, as described previously. The transformed cells 
were plated onto 50 μg/mL ampicillin (Sigma) Luria Broth (LB) agar (Merck) plates and the 
plates are incubated at 37ºC overnight. 
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3.7.4 Identification of recombinant clones 
 
The identification of transformed clones was assessed by the use of LB agar containing 
the antibiotic ampicillin (Sigma) 50 μg/mL.  
 
 
3.8 PCR 
 
Polymerase Chain Reaction or PCR is an in vitro technique based on the principle of 
DNA polymerisation reaction that allows exponential amplification of a specific DNA fragment, 
resulting in millions of copies. It relies on thermal cycling, consisting of repeated cycles of 
heating and cooling of the reaction for DNA melting and enzymatic replication of the DNA 
using thermostable DNA polymerase, primers (short DNA fragments complementary to target 
region), dNTPs, appropriate concentration of MgCl2 (Mg+ ions are essential for the polymerase 
operation) and a suitable buffer. It was invented by Kary Mullis in 1993 who was awarded the 
Nobel Prize in Chemistry for developing PCR. 
“Beginning with a single molecule of the genetic material DNA, the PCR can generate 
100 billion similar molecules, in an afternoon. The reaction is easy to execute. It requires no 
more than a test tube, a few simple reagents, and a source of heat. The reaction is easy to 
execute. It requires no more than a test tube, a few simple reagents, and a source of heat” 
(Mullis, 1990).  
In a PCR tube, on ice, x ng DNA template (~30 ng plasmid DNA or ~300 ng genomic 
DNA), 10 μL 5X PCR Buffer (including Mg2+), 0.5 or 1 μL dNTP mix 10 mM (10 mM each 
dATP, dTTP, dGTP, dCTP), 1.25 μL forward primer 10 μM, 1.25 μL reverse primer 10 μM, 1 
μL polymerase 5u/µl and dH2O to 50 μL final volume were mixed. Thorough mixing and brief 
centrifugation followed.  
The standard PCR programme was comprised of: A denaturation step of 2 min at 95ºC 
followed by 30 cycles comprising of 30 seconds at 95ºC (denaturation), 45 seconds at, 
approximately, 5 ºC below the lowest Tm of the primers (primer annealing – approximately 5 ºC 
below the lowest Tm of the primer) and 1 min and 30 seconds at 72ºC (elongation) and 
concluded by a final elongation step of 3 min at 72ºC. 
 
 
3.8.1 Primer sequences for PCR 
 
PCR primers, generally, range in length from 15–30 bases and are designed to flank the 
region of interest. Primers should contain 40–60% (G + C), and care should be taken to avoid 
sequences that might produce internal secondary structure. The 3´-ends of the primers should not 
be complementary to avoid the production of primer-dimers, because primer-dimers 
unnecessarily delete primers from the reaction and result in an unwanted polymerase reaction 
that competes with the desired reaction. Ideally, both primers should have nearly identical 
melting temperatures (Tm); in this manner, the two primers should anneal at roughly the same 
temperature. 
Following the restrictions mentioned, there was manual design of gene specific PCR and 
RT-PCR primers based on the available P. berghei genome sequence and annotation. 
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3.8.1.1 RT-PCR 
 
The gene specific RT-PCR primers, following the cDNA synthesis, were designed to 
amplify the unique exons of the subject genes (Table 3.1).  The Tm was 50.8-53.9ºC and the 
length of the products of, approximately, ~0.2-0.6 Kb. 
 
 
Primer name Sequence (5′ to 3′) 
Pb_c57 F GAAGATAGTGATAGAAACAGTAG 
Pb_c57 R GACTGAAGAGTTTTCTACATATG 
Pb_c01 F CATTTTCCAAAGTATTCATATAC 
Pb_c01 R CTATAACCGTCTATTATTATTTTTC 
Table 3.1. Sequences of the primers used in RT-PCR. All primers are listed in a 5’ to 3’ direction. 
 
 
3.8.1.2 Diagnostic PCR of transfectants 
 
Diagnostic PCRs of transfectants were performed by using gene-specific forward (int fw) 
primers designed upstream of homology region A, in combination with the TgDHFR-TS 5'UTR 
reverse primer (Table 3.2). This primer positioning ensures that a product can only be obtained 
if integration taken place. Also, gene-specific reverse (wt r) primers were designed downstream 
of homology region A, within the coding region, which, in combination with the int fw primers, 
generate a product only if integration not taken place. Tm of the manually designed primers was 
53.6-64.6 ºC and the resulting products had length of ~0.9 bp. 
 
 
 
Primer name Sequence (5′ to 3′) Description 
Pb_c57 int fw GATGTCTAGCTAATTTGGGAATTAGTG 109 bp upstream of Pb_c57 A 
Pb_c57 wt r GCATTATCTCTATCTTCATAATTTG 218 bp downstream of Pb_c57 A 
Pb_c01 int fw GGATGTATTCCTATAACTATGTG 294 bp upstream of Pb_c01 A 
Pb_c01 wt r CTCCTTGTATGTTGCTGCTGG 111 bp downstream of Pb_c01 A 
tgdhfr-ts 5'UTR R GATGTGTTATGTGATTAATTCATACAC 200 bp into the  5'UTR of tgdhfr-ts 
Table 3.2. Primers for diagnostic PCR of transfectants. The position of the primers is presented in the 
description column. All primers are listed in a 5’ to 3’ direction. 
3.8.1.3 PCR amplification of homology regions and colony PCR of E. coli transformants 
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Gene specific primers with restriction enzyme site overhangs were manually designed 
with a Tm of 61.0-73.7ºC (Table 3.3). The homology regions corresponded to, approximately, 
430-750 bp of the 5' UTR and 3'UTR of the target-genes or the most upstream and downstream 
coding sequences, depending on the available ORF. 
 
Primer 
name Sequence (5′ to 3′) 
Description 
and 
restriction 
enzyme 
Pb_c57 a TTGGGCCCCTAATATATTATACATAGACAATTGCTC 
Disruption 
upstream 
target (A) 
ApaI 
Pb_c57 b CCAAGCTTCATATATTGATATATGTATTTTAC 
Disruption 
upstream 
target (A) 
HindIII 
Pb_c57 c TGAATTCGGTACCATATAACTATTCTGAAGCATATG 
Disruption 
downstream 
target (B) 
EcoRI 
Pb_c57 d TTGGATCCGCTCATCATATAGAAAGTGGTATAATATATG 
Disruption 
downstream 
target (B) 
BamHI 
Pb_c01 a TTGGGCCCCCAATACAATAGTATGATAC 
Disruption 
upstream 
target (A) 
ApaI 
Pb_c01 b CCAAGCTTCCTCATTATTATAACTGGATGC 
Disruption 
upstream 
target (A) 
HindIII 
Pb_c01 c TGAATTCGAAACATAGTTTATGCATATTTTATG 
Disruption 
downstream 
target (B) 
EcoRI 
Pb_c01 d TTGGATCCGAAATTTAATCTTCCTCAATTAAG 
Disruption 
downstream 
target (B) 
BamHI 
Table 3.3. Primers for generation of ΔPb_ c57 and ΔPb_c01 transgenes. Where appropriate, target restriction 
sites are underlined. The appropriate restriction enzyme is presented in the description column. F, forward; R, 
reverse. All primers are listed in a 5′ to 3′ direction. 
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3.8.2 Reverse Transcription PCR transcriptional profiling 
 
Reverse transcription polymerase chain reaction (RT-PCR) is a variant of PCR 
commonly used in molecular biology, providing the possibility to assess gene transcription in 
cells or tissues. RT-PCR is used to clone expressed genes by reverse transcribing the RNA of 
interest into its DNA complement through the use of reverse transcriptase. Subsequently, the 
newly synthesised cDNA is amplified using traditional PCR. 
 
 
3.8.2.1 cDNA production 
 
Total RNA extracted from P. berghei ANKA 2.34 (WT) parasites obtained 1, 6, 10 and 
24 hours post-infection of A. gambiae N’gousho mosquito midguts (kind gift from Rajeev Rai, 
master student, Imperial College London) was used for generation of complementary double-
stranded cDNA through reverse transcription. The cDNA synthesis was performed using 
SuperScriptTM III Reverse Transcriptase (Invitrogen) and a combination of random hexamers and 
oligodT primers, according to manufacturer’s instructions. Briefly, ~5 μg total RNA, primers, 1 
μL dNTP Mix (10 mM) and dΗ2Ο to 13 μL were mixed and heated at 65ºC for 5 min before 
adding 4 μL 5X First-Strand Buffer, 1μL 0.1 M DTT and 2μL SuperScriptTM III Reverse 
Transcriptase and 60 min incubation at 50ºC. The reaction was heat inactivated at 70ºC for 15 
min and the resulting cDNA served as template for RT-PCR.  
 
 
3.8.2.2 Procedure of RT-PCR 
 
GoTaq Green DNA polymerase (Promega) and gene specific primers were used to 
perform qualitative RT-PCR, at the proper annealing temperature.  
 
 
3.8.3 PCR amplification of homology regions  
 
PCR amplification of upstream (A) and downstream (B) homology regions for the 
introduction of targeted gene disruption through homologous recombination was accomplished 
using Herculase II Fusion polymerase (Agilent) or GoTaq Green DNA polymerase (Promega).  
 
 
3.8.4 Colony PCR of transformed E. coli 
 
Colony PCR is a quick method of screening for plasmid inserts directly from E. coli 
colonies. Also, it is useful in order to determine insert size. As a result, recombinant transformed 
E. coli colonies were identified through diagnostic colony PCR. GoTaq Green DNA polymerase 
(Promega) and the same gene specific primers which were used for the initial amplification of 
upstream (A) and downstream (B) homology regions were also used for the diagnostic colony 
PCR.  
In a PCR tube, on ice, 5 μL of the colony were mixed with 5 μL 10X Buffer, 0.5 μL 
dNTP mix 10 mM (10 mM each dATP, dTTP, dGTP. dCTP), 1 μL forward primer 10 μM, 1 μL 
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reverse primer 10 μM, 12 μL dH2O (for a total volume of 24.5 μL) and, in the end, 0.5 μL 
polymerase 5u/µl. 
 The PCR programme was as follows: An initial cell breakage and DNA denaturation step 
of 5 min at 95ºC followed by 30 cycles comprising of 30 seconds at 95ºC (denaturation), 45 
seconds at, approximately, 5 ºC below the lowest Tm of the primers (primer annealing – 
approximately 5ºC below the lowest Tm of the primer) and 1 min and 30 seconds at 72ºC 
(elongation) and concluded by a final elongation step of 3 min at 72ºC. 
 
 
3.8.5 Diagnostic PCRs of transfectants  
 
GoTaq Green DNA polymerase (Promega) was used and PCR procedure was performed 
as previously described (at the appropriate annealing temperature). 
 
 
 
3.9 Ttransfection procedure (Janse et al. (2006)) 
 
3.9.1 Preparation of schizonts  
 
Prior to starting transfections, the parasite quality and quantity was verified by a Giemsa 
stained smear. Viable schizonts were purified from schizont overnight cultures, as described 
before. The pellet was re-suspended in schizont culture media, split into 1 mL aliquots and spun 
down for 1 min at 200 g. 
 
 
3.9.2 AMAXA transfection procedure / electroporation 
 
The supernatant from previous step was discarded and the pellet re-suspended in 100μL 
AMAXA supplemented nucleofector (AMAXA) containing the DNA which was to be 
transfected. Exactly 100 μL of the DNA / buffer / parasite solution were transferred to an 
electroporation cuvette (AMAXA) and electroporation was performed according to Protocol 
U33; AMAXA. The electroporated parasites were transferred to 150 μL of uninfected mouse 
blood (collected from a PH treated mouse on day 2-3 after treatment) and were incubated at 37ºC 
for 20 min to allow invasion of merozoites into erythrocytes before IP injection of the suspension 
into a mouse.  
 
 
3.9.3 Pyrimethamine-based selection of transgenic parasites 
 
Twenty-four to thirty hours after ransfection, 0.07 mg / pyrimethamine (Sigma) was 
administered orally with the drinking water of host mice in order to select the pyrimethamine-
resistant (transgenic) parasites. The selection was performed in both of the mice used for the 
parasite production (one passage in between).  
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3.9.4 Limited dilution cloning of transgenic parasites 
 
Clonal transgenic parasite populations (derived from one cell) were obtained by limited 
dilution cloning (Waters et al., 1997a). Infected tail blood was diluted in 10 mL schizont culture 
medium and blood-stage parasites were enumerated on a haemocytometer. The diluted sample 
was further diluted in schizont culture medium to a final concentration of 20 parasites / mL, prior 
to IP injection (200 μL) into ten TO mice. 
 
 
3.10 Phenotypic analysis of mutants 
 
3.10.1 In vitro phenotypic analysis 
 
3.10.1.1 Exflagellation assay 
 
Exflagellation was examined on day 4–5 post-infection. Exflagellation assays were 
conducted by transferring 4 μL of parasite infected tail blood in 150 μL ookinete culture 
medium. After 10 min of incubation at room temperature, exflagellation was observed by phase 
contrast microscopy at 40X magnification in a standard haemocytometer (Hausser Scientific, 
USA), where enumeration of exflagellation centres and RBCs (proportion of exflagellating male 
gametocytes) was done. In parallel, male gametocytaemia (total proportion of male gametocytes) 
was determined by Giemsa stained tail-blood smears. These two resulting proportions were 
compared and the percentage of male gametocytes that exflagellated was calculated. 
 
 
3.10.1.2 Ookinete conversion assays 
 
3.10.1.2.1 Ookinete conversion assay, method no1 
 
The total female gametocytaemia (total proportion of female gametocytes) was 
determined in Giemsa stained thin tail-blood smears. The number of ookinetes was determined 
by counting the number of live ookinetes and number or RBC (proportion of ookinete converted 
gametocytes) on a standard haemocytometer at 40X magnification, 24h after in vitro cultivation 
of infected blood (described earlier), of the same mouse, in ookinete culture medium. These two 
proportions were directly compared and the conversion rate was resulted. 
 
 
3.10.1.2.2 Ookinete conversion assay, method no2 
 
After 24 hour ookinete cultivation, macrogamete to ookinete conversion assays were 
implemented using a haemocytometer in ookinete medium, using a Cy3 conjugated P28 (13.1) 
monoclonal antibody (mAb13.1), as previously described (Billker et al., 2004). After 
centrifugation at 500g for 5 min of 0.5 mL of the ookinete culture samples, the pellets were 
resuspended in 0.5 mL mAb13.1 diluted to 1:500 in ookinete medium and incubated on ice for at 
least 50 min. The total number of fluorescent ookinetes was divided by the total number of 
fluorescent macrogametes resulting in the conversion ratio. 
Institutional Repository - Library & Information Centre - University of Thessaly
09/12/2017 03:13:53 EET - 137.108.70.7
53 
 
3.10.2 In vivo phenotypic analysis 
 
3.10.2.1 Mosquito midgut sample preparations for enumeration and imaging 
 
Following dissection, midguts were immediately mounted in PBS on glass slides under 
cover-slips. Alternatively, midguts were fixed in 4% formaldehyde (v/v) (16% methanol free, 
ultra-pure stock diluted in PBS, Polysciences Inc.) for 20 min at room temperature before 
washing in cold PBS three times for ten minutes each. Afterwards, formaldehyde fixed midguts 
were placed in Vectashield Mounting Medium with or without DAPI (Vector Labs) on glass 
slides under sealed cover-slips and slides were stored in the dark at 4ºC until imaging. Oocyst 
counting was conducted with the aim of using a minimum of 50 infected midguts per parasite 
genotype and sporulating oocysts were imaged with the aim of using a minimum of 3 infected 
midguts per parasite genotype. 
 
 
3.10.2.2 Sporozoite enumeration 
 
Salivary gland sporozoite numbers were calculated from homogenated P. berghei 
infected A. stephensi or A. gambiae salivary glands, assayed in three batches of ten salivary 
glands on day 19-22 post-infection. Dissected salivary glands were immediately transferred to a 
0.1mL glass tissue homogeniser (Jencons England, VWR), containing 100 μL of ice-cold PBS 
and mechanically homogenised to release the sporozoites. The final volume of the suspension 
was carefully measured using a Hamilton syringe (Hamilton Company Ltd.) and 10 μL were 
loaded onto a haemocytometer. The calculation of the total number of sporozoites per 10 
mosquitoes was assisted by the final volume measurement.  
 
 
3.10.2.3 Transmission to mice 
 
Sporozoite infectivity was assayed by bite-back experiments, were P. berghei infected 
mosquitoes (day 18 and 21 post-infection) were allowed to feed on anaesthetised TO or 
for 15 min. The mice were then allowed to recover and parasitaemia was C57BL/6 mice 
monitored, by Giemsa stained tail-blood smears, on day 7-10 following the potential infection. 
Infected or uninfected mice were culled at the end of the experiment.  
 
  
3.10.3 Microscopy (parasite enumeration and imaging)  
 
After P. berghei infected midguts dissection, oocysts were enumerated at X10 or X20 
magnification and the sporulating oocysts were imaged at X20 magnification (light and 
fluorescence microscopy; Pbc507 GFP reference lines). Also, ookinetes and macrogametes 
rendered in the in vitro ookinete conversion assay were counted at X20 magnification 
(fluorescence microscopy; Cy3 monoclonal antibody). Parasites were imaged using a Zeiss 
AxioImager M2 (Carl Zeiss, Inc) microscope using fluorescence microscopy. Images captured 
using a Zeiss AxioCam HRc (Carl Zeiss, Inc) camera coupled to Zeiss Axiovision40 version 
4.6.1.0 software. 
 
Institutional Repository - Library & Information Centre - University of Thessaly
09/12/2017 03:13:53 EET - 137.108.70.7
54 
 
3.11 Bioinformatics 
 
3.11.1 Analysis of P. falciparum gene expression in A. gambiae and A. arabiensis  
 
 For the analysis and visualisation of microarray data of P. falciparum gene expression in 
A. gambiae and A. arabiensis, Cluster 3.0 and TreeView were used.  
Cluster and TreeView is an integrated pair of programs for analysing and visualizing the 
results of complex microarray experiments. They are both developed by Michael Eisen while at 
Stanford Univeristy. Cluster offers a variety of types of cluster analysis and other types of 
processing on large microarray datasets and TreeView graphically browses results of clustering 
and other analyses from Cluster. Cluster 3.0 is an enhanced version of Cluster, developed by 
Michiel de Hoon of the University of Tokyo (de Hoon et al., 2004) (Saldanha, 2004).  
Four distinct groups of parasite transcripts displaying significantly differential regulation 
upon timepoints (>0.7 in log2 scale) were generated, according to their developmental pattern 
with Self-Organizing Map clustering, via “euclidian distance” similarity metric method (initial 
tau value: 0.02) using Cluster 3.0. TreeView was utilised for the visualisation of the clustering 
results. 
 
 
3.11.2 Candidate gene selection and in silico analysis 
 
PlasmoDB is a functional genomic database for Plasmodium spp. that provides a resource 
for data analysis and visualisation in a gene-by-gene or genome-wide scale. PlasmoDB belongs 
to a family of genomic resources that are housed under the EuPathDB Bioinformatics Resource 
Center (BRC) umbrella. The latest release, PlasmoDB 5.5, contains numerous new data types 
from several broad categories annotated genomes, evidence of transcription, proteomics 
evidence, protein function evidence, population biology and evolution (Aurrecoechea et al., 
2009). Sequence, general data and Plasmodium orthologs were queried by the use of gene IDs. 
(http://plasmodb.org/plasmo/). 
Also, protein structure prediction was assayed by PROTEUS2, for further investigation 
for potential domains, such as secretory and/or transmembrane domains. PROTEUS2 is a web 
server designed to support comprehensive protein structure prediction and structure-based 
annotation. PROTEUS2 accepts either single sequences (for directed studies) or multiple 
sequences (for whole proteome annotation) and predicts the secondary and, if possible, tertiary 
structure of the query protein(s). Unlike most other tools or servers, PROTEUS2 bundles signal 
peptide identification, transmembrane helix prediction, transmembrane beta-strand prediction, 
secondary structure prediction (for soluble proteins) and homology modeling (i.e. 3D structure 
generation) into a single prediction pipeline (Montgomerie S. et al., 2008).     
 
 
3.11.3 Statistical analysis 
 
Basic statistic values (e.g. median, mean, standard deviation etc.) were calculated using 
Microsoft Excel, Microsoft.  
Statistic tests, such as χ2 test and U-test (Mann-Whitney), as well as graphing were 
performed by GraphPad Prism 5. GraphPad Prism 5 is a scientific 2D graphing and statistics 
software. It combines basic biostatistics, curve fitting and scientific graphing and is published by 
GraphPad Software, Inc. 
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CHAPTER 4: RESULTS 
 
4.1 Project strategy  
 
Aiming at the identification of possible P. falciparum targets for the generation of transmission 
blocking interventions, P. falciparum transcriptome during the stages when transmission 
bottleneck occurs should be analysed.  Thus, the first step of the project strategy includes the 
selection of candidate genes based on the P. falciparum genes expression upon mosquito 
infection, as illustrated by transcriptomic microarrays, and further in silico analysis. 
Subsequently, after the selection of the candidate genes, transgenic P. berghei parasites by 
targeted disruption of the homologous genes are generated in order to examine the impact of the 
gene deletion, to the parasite development and survival. P. berghei is used for this study due to 
the easy and safe manipulation of malaria infected mosquitoes (Sinden, 1996) and the facilitation 
to the experimental analysis of gene expression patterns, resulted from the unnaturally high 
infection levels in P. berghei compared to those in P. falciparum (Dong et al., 2006). Also, in 
contrast to P. falciparum, it is also possible to easily in vitro cultivate and purify different P. 
berghei vector stages (Janse and Waters, 1995).  The phenotypic characterisation of the 
generated mutant parasites could provide information about the significance and the possible role 
of the knocked-out genes to the parasite development and/or parasite-mosquito interactions 
during the outlined stages.    
During this project, four candidate genes were selected through in silico analysis but the 
gene disrupted mutant parasites of only two of them were generated. The other two lines of KO 
mutant parasites were generated by R. Rai. All four transgenic parasite lines were phenotypically 
analysed during this study.  
 
 
 
Figure 4.1. Illustration of the project strategy. 1) In silico analysis for the selection of the P. falciparum 
candidate genes for further phenotypic characterisation. 2) Generation of transgenic P. berghei parasites by 
targeted gene disruption (P. falciparum orthologs). 3) Phenotypic analysis of the generated KO parasites. 
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4.2 Selection of P. falciparum candidate genes 
 
 
The experimental strategy of the microarray assay 
(D. Vlachou, unpublished data), results of which are 
considered in this project, was initiated in Burkina 
Faso, by parasitological surveys for gametocyte 
carriers, in collaboration with local medical groups 
in primary schools. The collected blood samples, 
containing only one Plasmodium species, were 
subjected to serum replacement, with the aim of 
elimination of transmission blocking factors 
included in the blood plasma. The samples were 
divided in two experimental groups: the infection 
group, in which mosquitoes were infected with 
infectious parasites, and the control group, in which 
mosquitoes were infected with heat-inactivated 
(non-infectious) gametocytes, via membrane 
feeding in both cases. Infected mosquito midguts 
were dissected for total RNA extraction in four 
distinct time points, from both experimental groups. 
The four time points correspond to the midgut 
lumen stages of Pasmodium developement: 
gametogenesis and zygote formation (T1); zygote 
maturation and early motility (T2); ookinete 
locomotion (T3); midgut invasion and ookinete-to-
oocyst transition (T4). This experimental assay was 
performed for both A. gambiae and A. arabiensis 
infections with sympatric P. falciparum 
populations. In order to identify the molecular 
interactions between mosquito and parasite, at the 
mentioned time points during these infections, a 
high-throughput screening approach was followed, 
using transcriptomic microarray technology.   
Data extracted from analysis of the previously described microarrays (Nikolaos 
Trasanidis, final year project thesis, 2013), revealed P. falciparum transcript expression in the 
four distinct timepoints (1h, 4h, 10h and 24h) upon infection in the two major vectors A. 
gambiae and A. arabiensis.  
SOM-based clustering performed in significantly differential regulated genes disclosed 
four major developmental patterns, similar in both infection types (Figure 4.3). Interestingly, two 
of the four clusters demonstrated a peak in specific developmental timepoint, implying a time-
specific role of the genes involved. Specifically, transcripts included in C2 cluster display a 
developmental enhancement in 10h post-infection (ookinete stage prior to midgut invasion) and 
transcripts included in C4 cluster in 24h post-infection (ookinete stage during midgut invasion). 
Genes expressing the implying transcripts provide an intriguing pool for further functional 
characterisation, due to their potentially significant role to these stages of the parasite life cycle 
and/or the mosquito parasite interactions developed in the midgut. 
 
Figure 4.2. Experimental strategy of 
microarray assay design and. (Details in the 
main text). 
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Figure 4.3. SOM-based clustering of significantly (0.7) differentially regulated Plasmodium genes. Stars 
indicate the gene clusters of high interest, from which the final candidate genes were selected. Left: Heatmap 
visualisation and SOM organisation. Right: Developmental trends of each cluster. The bold blue line 
repressents the average expression of the genes included in the cluster, the gray area depicts the genes' range 
(Maximum to Minimum) of expression. 
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  As mentioned earlier, although, the rodent parasites are not of direct practical concern to 
human, P. berghei is a practical model for the experimental study of mammalian malaria, due to 
their trend to be analogous to the human malarias in most essential aspects of structure, 
physiology and life cycle (Carter and Diggs, 1997). This is the reason why the existence of P. 
berghei orthologs of the candidate list genes has been an important criterion to the selection of 
the candidate genes. Specifically, information on the presence of P. berghei orthologs was 
provided by pre-computed BLAST results on PlasmoDB, assisting to the limitation of the 
number of the genes discriminated upon their expression profile and included in the previous 
pool. 
Data, considering the P. berghei orthologs, from P. berghei (GFPCON) infected A. 
gambiae (Yaounde) developmental arrays (D. Vlachou, unpublished data) were collected in 
order for investigation about the expression profile in P. berghei to be done. The microarrays 
were reflecting distinctive P. berghei developmental stages: mixed asexual and sexual 
bloodstages (1 hour PI), invading ookinete (24 hours PI), young oocysts (2 days PI), mid-oocyst 
(5 days PI), mature oocyst (10 days PI) and sporozoite release in the haemocoel (13-15 days PI).  
Transcriptomic microarrays illustrating the expression profiles of P. berghei WT 2.34 
strain and the 2.33 non-gametocyte producing parasite strain at 1 hour PI (mixed asexual and 
sexual bloodstages-gametocytes)  of A. gambiae (Yaounde) (D. Vlachou, unpublished data), 
provided evidence about the expression of the genes in the first sexual stage of the parasite, the 
gametocytes. 
Additionally, the expression profile of the genes was further examined considering 
published and unpublished transcriptome and proteome data about P. falciparum and P. berghei 
(Hall et al., 2005; Khan et al., 2005; Raibaud et al., 2006; Lasonder et al., 2002; Lasonder et al., 
2008; Le Roch et al., 2003; Young et al., 2005). This provided further assistance to the selection 
of genes showing similar expression trends and regulation during the sexual development of the 
parasite.  
 After this investigation of the expression profile of the genes and considering all the 
information yielded, the list gene candidates for functional analysis by targeted gene disruption 
was finally restricted to four preponderant genes, Pf_c57, Pf_c01, Pf_c53 and Pf_c22, which 
show significantly differential expression among the four examined time points and a 
developmental peak in one of these (Figure 4.4). Specially, of great consideration was a high 
expression in T3 or T4 time point, as described before, implying a potential significant role in 
these developmental parasite stages and/or the mosquito parasite interactions during these stages.  
Pf_c53 and Pf_c22 are differentially overexpressed at 10 hours post-infection, meaning 
in the ookintete maturation and locomotion stage, while Pf_c57 and Pf_c01 show a differential 
overexpression at 24 hours post-infection, in the midgut invasion and ookinete-to-oocyst 
transition stage (Figure 4.4).  
Also, Pb_c53 and Pb_c22 show significantly high expression in the gametocyte stage, 
while no data were available for Pb_c57 expression in gametocytes. According to the 
developmental arrays, Pb_c53 is highly expressed in the first sexual stages, Pb_c22 during the 
midgut invasion and the sporozoite release in the haemocoel stage and Pb_c57 in the invading 
ookinete, while downragulated in other stages. No data about Pb_c01 expression were available 
from these two microarray experiments. 
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Figure 4.4.Transcriptional profiling of P. falciparum candidate genes in A. gambiae and A. arabiensis. 
Distinctive peaks of relative expression (log transformed data) of Pf_c53 and Pf_c22 at 10 hours post-
infection, corresponding to ookinete pre-invasion stage and of Pf_c57 and Pf_c01 at 24 hours post-infection, 
corresponding to ookinete during the midgut invasion and ookinete-to-oocyst transition stage (data obtained 
from microarray analysis). The red stars indicate proteome derived data and the blue stars transcriptome 
derived data revealing expression of these genes in the stages highlighted. Vertical axis: relative expression in 
log2 scale. 
 
 
 
Figure 4.5. Graphical presentation of P.berghei orthologous candidate genes expression in A. gambiae and 
additional evidence of published transcriptome and proteome data about their expression in the highlighted 
stages, indicated by blue and red stars, respectively. Vertical axis: relative expression in log2 scale. 
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Finally, the selected P. falciparum gene candidates were subjected to further 
investigation about their functional domain predictions (Figure 4.6), apart from expression 
profiles indicated in microarrays and other published data (Figures 4.4 & 4.5). Homology with 
other eukaryotic genomes could provide an assignment of functional domains in the predicted 
proteins encoded by Plasmodium. An obstacle to this strategy is the extreme AT-richness of the 
P. falciparum and rodent Plasmodia genomes resulting in lack of any functional domain 
predictions of roughly 60% of predicted proteins. 31% of the predicted proteins possess one or 
more transmembrane domains while, approximately, 17% of the proteins have putative signal 
peptides or signal anchors (Gardner et al., 2002).  
The presence of predicted transmembrane domains in the derived proteins of Pf_c57 and 
Pf_c01 genes (surface-located proteins) could suggest involvement in interactions between the 
parasite and the mosquito vector. Pf_c53 and Pf_c22 lacking secretory and transmembrane 
domains could play an important role in parasite development through the underlined stages. 
Corresponding domains were predicted in the P. berghei orthologs. 
 
 
 
 
Figure 4.6. Schematic representation of protein features of Pf_c57, Pf_c01, Pf_c53 and Pf_c22. Signal peptide 
motifs and transmembrane domains were predicted for Pf_c57, Pf_c01 proteins. No functional domains were 
predicted for Pf_c53 and Pf_c22. 
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4.3 Generation of loss of function mutant parasites by targeted gene disruption 
 
4.3.1 Experimental strategies  
 
 
 
Figure 4.7. Schematic representation of the experimental strategies followed for the generation of each KO 
parasite line. After PCR amplification of target regions of homology and ligation to PCR vectors (1), the 
homology regions and the transfection vector (pBS/TgDHFR vector) are cut with the appropriate pairs of 
enzymes (2). The homology regions are ligated to the pBS/TgDHFR vector consecutively -a second restriction 
digest of the vector with the respective pair of enzymes mediating between the two ligations- (3, 4, 5). The 
resultant KO construct is linearized and used for transformation of parasite schizonts (6, 7). The parasites are 
cultivated and drug selected in mice hosts (8), before dilution cloning (9). Finally, a new KO parasite line is 
achieved after selection of the successfully transgenic parasite clones (10). The restriction sites used for vector 
linearization are indicated by yellow arrows. Homologous recombination, following transfection, is indicated 
by a red star and represented in the following figure. 
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4.3.2 Strategy for targeted gene disruption by homologous recombination  
 
The generation of gene-specific targeting constructs is the most efficient strategy for 
introduction of targeted gene disruption by homologous recombination, in P. berghei. Included 
in these constructs, a TgDHFR pyrimethamine resistance cassette is flanked by homologous to 
the targeted gene downstream and upstream regions (van Dijk et al., 1996). Homologous 
recombination occurs after transfection leading to integration of the disruption construct into the 
target locus (Figure 4.8).   
 
 
Figure 4.8. Representation of targeted gene disruption through homologous recombination in P. berghei. The 
regions for homologous recombination between the WT locus target and the corresponding fragments included 
in the disruption vector are indicated in beige. The TgDHFR cassette is shown in bright red with its 5' UTR 
promoter and 3' UTR regions indicated by red shading. Beige arrows show the position of the primers used for 
sub-cloning, the green arrows the assessment of wild-type (Int Fw and WT R primers) and the red arrows the 
detection of integration (Int Fw and 5’ UTR R). The black arrows indicate the position of the restriction sites 
and the restriction enzymes used for linearization of the KO construct.  
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4.3.3 Qualitative confirmation of expression of P. berghei candidate genes 
 
In order for the expression of the candidate genes to be experimentally examined, RT-
PCR was conducted. A. gambiae N’ gousho mosquitoes infected with P. berghei ANKA 2.34 
(Wild-type) were used for the qualitative in vivo verification of the genes expression in four 
time-points. RNA was extracted from A.gambiae/P.berghei infected midguts (kind gift from R. 
Rai), dissected at 1, 6, 10 and 24 hours post-infection, and was used as template for the RT-PCR. 
The RT-PCR product of Pb_c57 corresponded to 576 bp of the predicted RNA product, Pb_c01 
product to 252 bp, Pb_c53 product to approximately 550 bp and Pb_c22 product corresponded to 
approximately 780 bp. RT-PCR confirmed in vivo Pb_c53 and Pb_c22 expression at 10 hours 
post-infection and Pb_c57 and Pb_c01 24 hours post-infection, and generally in the sexual 
stages (Figure 4.9). 
  
 
Figure 4.9. In vivo Pb_c57, Pb_c01, Pb_c53 and Pb_c22 expression in infected A. gambiae mosquitoes with 
P.berghei. RT-PCR performed using RNA extracted from A.gambiae/P.berghei infected midguts, dissected at 
1, 6, 10 and 24 hours post-infection, as template. (RT-PCR of Pb_c53 and Pb_c22 was performed by R. Rai). 
 
 
4.3.4 PCR amplification of homology regions  
 
P. berghei genomic DNA was extracted from infected mouse blood, to serve as template 
for the amplification of the homology regions of genes Pb_c57 and Pb_c01. The upstream target 
region of Pb_c57 corresponded to 591 bp of the 5’ UTR and the downstream target region to 685 
bp of the most downstream coding sequence, inducing a partial disruption. The upstream 
homology region of Pb_c01 corresponded to 430 bp of the 5’ UTR and the most upstream 
coding sequence and the downstream homology region to 715 bp of the 3' UTR generating a 
partial knock-out, as well. After PCR amplification of these four regions, the quality of the 
products (product length, possible contamination) was verified using agarose gel electrophoresis 
(Figure 4.10) and the PCR products were purified. The concentration of purified PCR products 
was determined spectrophotometerically. 
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4.3.5 PCR-vector ligation and transformation 
 
Each PCR purified product was concentrated to the desirable final volume and cloned to 
an appropriate PCR-vector. PCR products of homology regions A and B of Pb_c57 and 
homology region B of Pb_c01 were cloned to blunt vector and PCR product of homology region 
B of Pb_c01 was cloned to T-vector. The resulting vectors were transformed into chemically 
competent Escherichia coli cells, having kanamycin resistance, by heat shock methodology. The 
cells were cultivated overnight LB agar plates containing kanamycin. Kanamycin assisted to the 
selection of transformed clones; only the transformed clones were resistant to kanamycin, due to 
the kanamycin resistance gene contained in the plasmid (PCR-vector).  
Clones containing the recombinant plasmids were identified through diagnostic digestion 
with EcoRI. Both PCR vectors accommodate two EcoRI restriction sites which flank the insert 
(Figure 3.2). A restriction digest by EcoRI results in a product slightly larger than the original 
insert.   
Overnight cultures in 50 μg /mL kanamycin LB medium were done after selection of the 
recombinant transformants in order for large quantity of recombinant cells, and therefore large 
quantity of plasmids, to be obtained. Plasmid DNA was extracted and purified from the 
overnight cultures.  
 
 
4.3.6 First restriction digests 
 
Purified plasmids, containing each homology region, were digested using the appropriate 
couple of restrictrion enzymes (Table 3.3). pBS/TgDHFR vector, in which polylinker sites flank 
a tgdhfr-ts pyrimethamine resistance cassette, was also cut by the same couple of restriction 
enzymes with the homology region which was going to be subcloned. The purpose of this 
restriction digest was to linearise the homology regions and the pBS/TgDHFR vector and 
generate complementary sticky ends for further subcloning. Preparative standard gel 
electrophoresis was used in order to distinguish and obtain the desirable digestion products 
Figure 4.10. PCR products of amplified homology 
regions.  
A. Herculase PCR product of homology region A 
(Pb_c57 a and Pb_c57 b primers) of Pb_c57 gene. 
B. PCR amplified homology region B (Pb_c57 c and 
Pb_c57 d primers) of Pb_c57 gene, using Herculase. 
C. PCR product of amplified homology region A of 
Pb_c01 gene (Pb_c01 a and Pb_c01 b primers), using 
Go-Taq polymerase 
D. Herculase PCR product of homology region B of  
of Pb_c01 gene (Pb_c01 c and Pb_c01 d primers) 
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(Figures 4.11 & 4.12). After electrophoresis, the appropriate digestion products were extracted 
from the agarose gel. The concentration of purified digestion products was determined 
spectrophotometerically in order to calculate the vector/insert ratios for the ligation reactions.  
 
  
 
Figure 4.11. Restriction digest of pBS/TgDHFR vector. 
A. map of pBS/TgDHFR vector. The couples of restriction enzymes used for each linearization aiming to 
further ligation are highlighted in red (HindIII, ApaI) and green (EcoRI, BamHI) squares.  
B. pBS/TgDHFR vector cut with ApaI and HindIII (red square) and transfection vector digested with EcoRI 
and BamHI (green square). 
 
  
Figure 4.12. Preparative electrophoresis of double digested 
PCR vectors containing inserts. Red highlight: Pb_c57 
homology region A cut with ApaI and HindIII, green 
highlight: Pb_c57 homology region B cut with EcoRI and 
BamHI. The upper bands represent the linearized PCR 
vector. 
 
 
 
4.3.7 First ligation to transfection vector 
 
Depending on the couple of restriction enzymes used in the digestion of the 
pBS/TgDHFR vector, the appropriate homology region (cut by the same couple of restriction 
enzymes) was firstly subcloned. For Pb_c57 KO construct, homology region A was firstly 
subcloned to pBS/TgDHFR vector in contrast to Pb_c01 KO construct for which homology 
region B was firstly subcloned to the vector. After the ligation of the first homology regions to 
the pBS/TgDHFR vector, followed by heat shock transformation of chemically competent E. coli 
cells, the resulting transformants were cultivated overnight in LB agar plates containing 
ampicillin. Ampicillin assisted to the selection of transformed clones, due to the presence of 
ampicillin resistance gene in the pBS/TgDHFR vector (Figure 3.3). Clones containing the 
recombinant plasmids were identified and selected through diagnostic colony PCR (Figure 4.13).  
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Overnight cultures in 50 μg /mL ampicillin LB medium were done after selection of the colonies 
including the recombinant pBS/TgDHFR vector. Plasmid DNA was extracted and purified from 
the overnight cultures. 
 
 
 
 
4.3.8 Second restriction digestions, ligations and transformations 
 
Purified transfection vectors, including one 
homology region, were digested using the same 
couple of restriction enzymes used for the digestion of 
the second homology region (Table 3.3). Specifically, 
complementary overhangs were generated to Pb_c57 
homology region B and the pBS/TgDHFR vector 
containing the Pb_c57 homology region A through 
double digestion with EcoRI and BamHI for further 
subcloning. Pb_c01 homology region A and 
pBS/TgDHFR vector containing the Pb_c01 
homology region B were cut with ApaI and HindIII 
for the same purpose. 
Preparative standard gel electrophoresis and gel 
extraction of the befitting products were performed 
before continuing to the ligation reactions of the 
second homology regions and the vectors. 
The final ligations and transformations followed the same methodology as the initial 
ones. Overnight cultures of the selected colonies were performed in 200 ml ampicillin LB 
medium, providing a high concentration of final recombinant plasmids, following extraction, 
required for the transfection procedure.  
 
 
 
   
Figure 4.14. Preparative electrophoresis after 
second restriction digests. 
A. transfection vector containing Pb_c57 
homology region A, cut with EcoRI and 
BamHI  
B. transfection vector containing Pb_c01 
homology region B, cut with ApaI and 
HindIII. 
 
Figure 4.15. Diagnostic colony PCR of inserts within the 
pBS/TgDHFR vector. Colony PCR amplified homology region A 
of Pb_c01 contained within the transfection vector including 
homology region B, after subcloning.   
 
Figure 4.13. Diagnostic colony PCR of inserts within the 
pBS/TgDHFR vector. Colony PCR amplified homology region A 
of Pb_c57 contained within the transfection vector, after 
subcloning. 
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A diagnostic quadruple digestion of the purified plasmids, using all four restriction 
enzymes (ApaI, HindIII, EcoRI and BamHI), was performed before the final double digestion. 
This provided the verification of the double recombination of the pBS/TgDHFR vector, resulting 
to the desirable KO constructs. Also, before transfection, pBS/TgDHFR vectors carrying the 
homology regions were sent for sequencing to Beckman Coulter Genomics, UK, for the 
verification of successful generation of the KO constructs. 
 
  
Figure 4.16. Diagnostic quadruple digestion before transfection. Digested regions of 
homology of Pb_c01 gene and transfection vector. Red star: homology region B. 
Green star: homology region A. The two upper bands illustrate the two fragments of 
the digested pBS/TgDHFR vector. 
 
 
 
4.3.9 Preparation of DNA for transfection 
 
The constructs were linearised prior to transfection because linear DNA renders optimal 
integration into the P. berghei genome despite the fact that it results in lower DNA uptake by the 
cells relative to supercoiled DNA. Final overnight double digestion of the constructs was 
conducted using the ApaI and BamHI (ApaI-restriction site added in forward primers of 
homology region A and BamHI-restriction site added in reverse primers of homology region B), 
so to release the disruption cassette (Homology region A - tgDHFR-TS - Homology region B). 
The desirable fragment was gel extracted and subsequently purified by ethanol precipitation for 
high purity and quality of the DNA to be acquired.  
 
 
Figure 4.17. Final restriction digests of pBS/TgDHFR vectors 
carrying the homology regions, before transfection. A. 
construct for double homologous recombination of Pb_c57 
gene.  
B. construct for double homologous recombination of Pb_c01 
gene. 
Constructs participating in homologous recombination 
highlighted in red squares.  
 
 
 
4.3.10 Transfection 
 
After the transfection procedure outlined earlier, ΔPb_c57 and ΔPb_c01 transgenic 
parasites, selected in vivo by two pyremethamine treatments of infected mice were subjected to 
diagnostic PCR in order to assign whether surviving parasites carried integrated disruption 
constructs, and consequently a gene specific KO locus. Genomic DNA of P. berghei transfected 
parasites was extracted and subsequently used as a template for PCR amplification (Figure 4.18). 
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Integration is easily detected through PCR, using gene specific forward primers and a 
reverse primer located inside the 5’UTR region of the TgDHFR cassette (Figure 2.4). Also, 
detection of gene specific WT loci is facilitated by the use of the same gene specific forward 
primer and a reverse primer situated inside the target coding region. Each of these two loci can 
be detected either in clonal or non-clonal parasite populations (Figure 4.8).   
 
 
Figure 4.18. Genotyping of the transfected P. berghei parasite populations after two pyrimethamine selections.  
A. Successful integration of ΔPb_c57 parasite population displaying absence of WT parasites. 
B. Presence of successful integration in ΔPb_c57 parasite population. 
 
 
Ten days after the limited dilution cloning, the presence of blood-stage parasites in the 
ten injected mice was examined by Giensa stained thin blood-smears. Blood from the infected 
mice was collected by cardiac puncture and 200 μL were used as template for diagnostic PCR 
while the remaining blood was preserved in glycerol stocks. 
Limited dilution cloning of the trasfected population yielded one ΔPb_c57 clone and five 
ΔPb_c01 clones which demonstrated successful clonal integration. In these clones PCR detected 
only the disrupted locus, but not the WT locus (Figure 4.19). 
 
 
Figure 4.19. Genotypic analysis of clones after dilution cloning showing successful integration. Diagnostic 
PCR analysis of ΔPb_c57 and ΔPb_c01 clonal selection.  
A. Successful integration in one clone of ΔPb_c57.  
B. Successful  integration in two ΔPb_c01  clones (clone 2 and clone 3) and unsuccessful integration in 
ΔPb_c01 clone no1. Extracted gDNA from P. berghei ANKA 2.34 parasite clone was used as template for 
negative control. 
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4.4 Phenotypic characterisation of transgenic parasites  
 
After the generation of four transgenic KO parasite lines (ΔPb_c57, ΔPb_c01, ΔPb_c53 and 
ΔPb_c22) they were subjected to in vivo and in vitro phenotypic analysis.  
 
4.4.1 In vitro phenotypic analysis 
 
On day 4–5 after the infection of PH treated mice with the transgenic parasite lines and 
WT Pbc507 parasites, assisting as biological control, exflagellation assay was performed. Blood 
was collected by cardiac puncture in order to be used for 24 hour ookinete cultivation, from the 
same mice used for the exflagellation assays. As a result, ookinete formation was assessed one 
day after the exflagellation assay. After confirmation of mature ookinete production through 
Giemsa stained smears, ookinete conversion assays were conducted. The biological replicates of 
in vitro assays were three for each transgenic parasite line.  
Giemsa staining of male and female mutant gametocytes illustrated no different staining 
pattern than the typical for P. berghei gametocytes and a typical female to male sex ratio, as 
well. Also, Giemsa stained transgenic ookinetes, cultivated in vitro, revealed a morphologically 
normal crescent shape. Staining with anti-Pbs21-Cy3 demonstrated that the rate of in vitro 
formation of ookinetes from female macrogametes is comparable to that of the WT and 
exflagellation assay showed a typical rate of exflagellated mutant male gametocytes compared to 
the WT (χ2 test).  
 
 
Figure 4.20. Graphical presentation of results of in vitro phenotypic assays. No significant difference was -
observed in the exflagellation (A) or the macrogamete to ookinete conversion (B) percentage of the four KO 
mutants compared to the wt (χ2 test: p value > 0.05). Error bars represent the standard error of the mean of the 
three biological replicates. 
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4.4.2 In vivo phenotypic analysis 
 
In the beginning of in vivo phenotypic analysis, PH treated mice were infected with the 
transgenic parasite lines and Pbc507 wt line (biological control). When parasitaemia reached 2-
10% (assayed by Giemsa stained smears), A. gambiae and A. stephensi starved female 
mosquitoes –approximately 150 female mosquitoes for each parasite line in each biological 
replicate– were allowed to feed on the anaesthetised mice. The day of per os infection 
corresponds to day 0 of the assay. After the removal of the unfed females, on day 1 p.i., 
mosquitoes were maintained for another maximum 22 days. On day 8-10 p.i. P. berghei infected 
A. stephensi or A. gambiae midguts were dissected for oocyst counting and imaging (minimum 
30 total number of dissected midguts) and on day 15 for sporulating oocyst imaging. 4-7 days 
later (19-22 day p.i.) salivary glands were dissected for sporozoite enumeration. Sporozoites 
were enumerated in suspensions of 30 homogenised salivary glands, assayed in three batches of 
ten, for each parasite line (including WT). Bite-back experiment was performed on the same or 
next day of the salivary glands dissection in order to determine mutant sporozoite infectivity to 
mice. The presence of parasites in the mouse blood was assessed four to five days after the bite-
back assay by Giemsa stained smears. Finally, the blood-stage parasites were purified and 
subjected to genotyping through PCR in order to define the purity of clonal WT/KO population.  
Three biological replicates of A. stephensi infections were analysed for ΔPb_c53, 
ΔPb_c22 and ΔPb_c57 and two for ΔPb_c01. Three A. gambiae infections with ΔPb_c53 and 
ΔPb_c22 and one infection with ΔPb_c57 and ΔPb_c01 were analysed. ΔPb_c53 and ΔPb_c22 
shared the same WT biological control in every biological replicate, both in A. gambiae and A. 
stephensi infections. 
Mosquito infections revealed that at day 8-10 post-infection that oocyst numbers in A. 
stephensi infected midguts of all the generated mutants were significantly reduced (P<0.05) 
compared to that of the WT control, according to Mann-Whitney analysis. Compared to the WT, 
oocyst numbers of ΔPb_c53, ΔPb_c01 and ΔPb_c57 in infected midguts were lower (P<0.001) 
than those of ΔPb_c22 (P=0.012). Specifically, in the absence of Pb_c53 severe disruption of 
oocyst development was observed (-21.76 fold difference between medians) (Table 4.1 and 
Figures 4.21, 4.22 & 4.23).  
A. gambiae infections could not provide results leading to safe conclusions about the 
phenotype of the mutant parasite lines due to low infection prevalence of the WT control or low 
parasitaemia of mice provided for infection (Tables 4.1 & 4.2, parasitaemia low in ΔPb_c01 
infection – data not provided). Only ΔPb_c57 infection can provide evidence, consistent to the 
results of A. stephensi infections.   
  
 
 
Figure 4.21. Transgenic parasite 
lines display a significant 
reduction in oocyst densities in 
A. stephensi / P. berghei 
infections. The transgenic oocyst 
numbers in A. stephensi 
expressed as a percentage of WT 
oocyst numbers. The percentages 
were calculated using medians. 
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Figure 4.22. Distribution of the four KO mutant and WT oocyst numbers in midguts of A. stephensi 
mosquitoes, at day 15 p.i. The medians of oocyst numbers are represented by red lines. Highly significant 
reduction (Mann-Whitney, P<0.001, ***) of ΔPb_c53, ΔPb_c22 and ΔPb_c01 oocyst numbers compared to 
WT controls is detected. Significant reduction (Mann-Whitney, P=0.012, *) of ΔPb_c57 oocyst numbers 
compared to WT control is also detected. 
  
 
 
Figure 4.23. Fluorescent microscopy images of GFP expressing oocysts in A.stephensi infected midguts at 
10X magnification (15 day p.i.). A.stephensi infected midguts with WT and transgenic parasites represent the 
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reduction in the oocyst numbers of the KO mutant parasites compared to the WT. Conspicuous reduction of 
oocyst density in ΔPb_c53 parasite line can easily be detected (highlighted in yellow borders). 
 
Table 4.1. 
This table reports results from ΔPb_c57, ΔPb_c01, ΔPb_c53, ΔPb_c22 and Pbc507 WT parasite infections of 
A. stephensi (upper section) and A. gambiae (bottom section). Equal numbers of transgenic or WT infected 
midguts were pooled for each group (total number of dissected midguts is shown in the fourth column). 
Prevalence illustrates the percentage of midguts with at least one oocyst. Midguts with zero parasites were also 
considered for the calculation of the arithmetic mean and median of parasite densities (number per midgut). P 
value (Mann Whitney) for each transgenic vs. WT group of infections was calculated using medians when 
available. Fold differences between wt and mutant oocyst densities were computed using the medians and 
arithmetic means. Values of fold differences using arithmetic means are shown in parenthesis.  
 
 
 
 
A.stephensi/P.berghei infections 
     Parasite intensity  
Mann Whitney 
Analysis 
Parasite 
line 
# 
Repli-
cates 
Day 
p.i. 
# 
midguts 
Infection 
prevalence 
(%) 
Arithme-
tic 
Mean 
Median Parasite Range P value 
Fold 
Differ-
rence 
wt 
3 8 
93 82.8 358.57 357 0-1082   
Δpb_c53 105 78.3 16,457 10 0-91 <0.0001 -21.76 (-35.7) 
Δpb_c22 91 85.7 226,308 203 0-837 0.012 -1.58 (-1.76) 
wt 
3 9 
116 95.7 303 207 0-1250   
Δpb_c57 120 87.5 145.175 82.5 0-792 <0.0001 -2.09 (-2.51) 
wt 
2 8 
66 92.4 413,348 365.5 0-1250   
Δpb_c01 106 98.1 192,472 142 0-880 <0.0001 -2.15 (-2.57) 
A.gambie/P.berghei infections 
wt 
3 9 
120 44.2 3.558 0 0-70   
Δpb_c53 142 0.7 0.007 0 0-1 - (-508.29) 
Δpb_c22 131 20.6 1.374 0 0-48 - (-2.59) 
wt 
1 8 
38 86.8 21.37 9 0-84   
Δpb_c57 49 65.3 6.1 3 0-38 0.002 -3 (-3.5) 
Δpb_c01 32 2.4 0 0 0-1 - - 
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At day 15 post-infection, the oocyst imaging revealed successful sporulation of a 
proportion of oocysts for all parasite lines. Also, although the oocyst developmental rate is non-
synchronous in P. berghei infections, resulting to heterogeneity even in the WT oocyst size, the 
average size of all mutant oocysts was comparable to the average size of WT oocysts (Figure 
4.23). 
 
 
Figure 4.24. Microscopic imaging of oocysts in A. stephensi infected midguts, at the stage of sporulation, on 
day 15 p.i. As WT, all mutant oocysts display normal size and efficient sporulation. Sporulating oocysts are 
shown by arrows and are magnified in highlighted borders.  
 
 
All ΔPb_c53, ΔPb_c22 and ΔPb_c57 biological replicates were finalised by enumeration 
of salivary gland sporozoites but none of the two replicates assayed for ΔPb_c01, in A. stephensi 
infections.  
As all transgenic parasites displayed successfully sporulating oocusts, sporozoites were 
detected in the salivary glands of A. stephensi mosquitoes of all assayed infections. Salivary 
gland sporozoite numbers were significantly reduced (Mann-Whitney analysis, P<0.05) in 
ΔPb_c53 and ΔPb_c57 infected A. stephensi mosquitoes but not in A. stephensi infected by 
ΔPb_c22, compared to the WT (Table 4.2). Although the sporozoite numbers were reduced, the 
feedback of all the bite-back assays was efficient infectivity to mice, as revealed by Giemsa 
stained smears.   
Also, although the infection prevalence of A. gambiae biological replicates was 
extremely low (Table 4.1), the presence of infective sporozoites in the salivary glands allowed 
successful transmission to mice, as confirmed by bite-back assays (Table 4.2). 
 
Institutional Repository - Library & Information Centre - University of Thessaly
09/12/2017 03:13:53 EET - 137.108.70.7
75 
 
 
Table 4.2.  
The table outlines mean Pbc507 wt or transgenic sporozoite densities in A. stephensi and A. gambiae salivary 
glands given as arithmetic mean per mosquito. SE represents standard error. Infectivity to mice was assayed by 
allowing transgenic or WT  infected mosquitoes to feed on one TO or C57BL/6 mouse (bite-back) at day 21-22 
of infection. Mice were allowed to recover and parasitaemia was assessed at day 5-6 post-feeding. 
  
A.stephensi/P.berghei infections 
Parasite 
line 
Day 
p.i. 
Parasite intensity 
SE 
Mann Whitney Analysis 
Bite-back 
assay # 
Replicates 
Arithmetic 
Mean 
P 
value 
Fold 
difference 
wt 
21-22 3 
2,821.36 397.186   √ 
Δpb_c53 659.42 69.016 <0.0001 -4.28 √ 
Δpb_c22 2,031.57 252.089 0.2224 -1.39 √ 
wt 
19 3 
2,632.44 198.514   √ 
Δpb_c57 1,373.33 267.232 0.0028 -1.92 √ 
A.gambiae/P.berghei infections 
wt 
19-20 2 
1,363.97 472.424   √ 
Δpb_c53 167.53 46.153 <0.0001 -8.14 √ 
Δpb_c22 665.33 230.033 0.2224 -2.05 √ 
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CHAPTER 5: DISCUSSION 
 
As malaria is characterised as one of the major infectious diseases in the world, causing 
hundreds of thousands deaths annually, mostly among African children, it is well understood 
why effective control measures are urgently needed. In the battle against malaria, several 
strategies have been developed, including targeting the Plasmodium parasite inside both hosts 
and controlling mosquitoes. Transmission blocking interventions are attracting much of the 
attention as they target the parasite’s development during transmission by the Anopheles vector, 
which represents the weakest link in malaria life cycle. The development of more effective 
approaches, though, requires the broadening of the existing knowledge about the parasite’s 
biology and the parasite-mosquito interactions. 
Although the sequencing of many Plasmodium spp, including the rodent model P. 
berghei, has been already completed, the limited knowledge about the functions of 
Plasmodium’s gene products comprises an obstacle to the development of successful 
transmission blocking interventions. This is the reason why a respectable proportion of the recent 
studies, including gene-candidate or high-throughput approaches, are focused on the 
understanding of Plasmodium’s biology gene-specific during sexual and sporogonic 
development and the molecular interactions between mosquitoes and malaria parasites.  
The aim of this project is focused on the identification of novel P. falciparum molecules 
that are essential to parasite’s sexual development, especially during the midgut invasion by the 
ookinete, and their products putatively interact with mosquito midgut molecules during the same 
period and their regulation has a prominent effect on the transmission capacity. The functional 
characterisation of these genes and their products could enforce not only the knowledge about 
parasite’s sexual and sporogonic differentiation mechanisms but also the further deployment of 
transmission blocking approaches as they could constitute novel effective targets of transmission 
blocking interventions. 
A genome wide transcriptional profiling of field isolated P. falciparum during infections 
in the two major African malaria vectors, A. gambiae and A. arabiensis (Host lab, unpublished 
data), revealed robust regulation of a group of P. falciparum genes in four distinct time points of 
the parasite’s development inside both Anopheles vectors (Nikolaos Trasanidis, final year 
project). The working hypothesis is that genes specifically up- and down-regulated 
during Plasmodium sexual and sporogonic development are likely to be implicated in parasite 
differentiation and interaction with the mosquito. The expression levels of some of these genes 
may determine the outcome of the parasite’s interaction with the mosquito immune and local 
epithelial response systems. As a result, the significantly regulated genes included in this 
analysis, and especially in the time points of interest, comprise intriguing targets for further 
investigation and functional characterisation (Figure 4.3).   
 Based on the evidence provided from the high-throughput screenings, four genes 
showing significantly differential expression in the sexual stages of Plasmodium’s lifecycle and 
a developmental peak in one of the distinct time points were selected as candidates for functional 
characterisation. The transcriptional peak of two of these genes was in the stage of ookinete 
maturation and locomotion (Pf_c53 and Pf_c22 in T3) and of the other two in the stage of 
midgut invasion and ookinete-to-oocyst transformation (Pf_c01 and Pf_c57 in T4) (Figures 4.4 
and 4.5). These transcription profiles are of high interest because they could illustrate the 
production of molecules that possibly regulate the procedure of midgut invasion (peak in T4) but 
also molecules that contribute to the successful maturation, motility of the ookinete could 
consequently regulate the early midgut invasion (peak in T3).   
 Then, the orthologues of these P. falciparum genes were identified in the rodent parasite, P. 
berghei and their expression profile determined during infection of A. gambiae. RT-PCR analysis (Figure 
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4.9) together with high-throughput transcriptional data of P. berghei in the mosquito midgut (Host 
lab, unpublished) showed that P. berghei ortholoques of c01, c57, c53 and c22 genes exhibiting a 
similar profile to their P. falciparum orthologues and thus they selected for further functional 
characterization.  
 Subsequently, the knock-out of these genes by homologous recombination in P. berghei 
was successfully conducted using strategies previously established, leading to the generation of 
four different transgenic parasite lines. These parasite clones were used during this study for the 
analysis of their resulting phenotype and can be further used for the completion of the 
phenotypic characterisation of the specific gene deletion.  
Interestingly, as revealed by the in vitro phenotypic assays, the deletion of these genes 
has no significant effect on the gamete production rate or morphology; both male and female, 
and produce morphologically normal ookinetes (Figure 4.20). This indicates that the functional 
role of these genes is focused on later stages of the Plasmodium development.   
Significant reduction in the oocyst numbers of the transgenic parasite lines compared to 
the wt was observed by the in vivo phenotypic analysis (Figures 4.21, 4.22 & 4.23). Specifically, 
on day 8-9 p.i. ΔPb_c22 oocyst numbers correspond to 57.98% of that of WT oocysts, ΔPb_c57 
to 39.86%, ΔPb_c01 to 38.85% and, finally and most importantly, ΔPb_c53 oocyst density 
reaches only 2.8% of that of WT (Figure 4.23). This provides strong evidence of critical 
involvement of all four genes in the parasite survival through the midgut invasion and/or 
ookinete-to-oocyst transition stage. 
All these results lead to the conclusion that the regulation of all the four examined genes 
has a semantic effect in the crucial stage of ookinete invasion and transformation to oocyst, when 
the major bottleneck in the parasite lifecycle occurs. The fact that there was no impact to the 
gametocyte production and fertilisation (ookinete conversion assay) or the sporozoite formation 
of the few oocysts, implements that the regulation of these four genes is restricted between the 
stages of ookinete maturation and motility, midgut invasion and transformation of the ookinete 
to oocyst. Pb_c53 seems to have the most effective involvement during these stages, as its 
deletion has the most protrusive phenotype.  
Although no reliable conclusions can be derived from the A. gambiae infections 
presented in this study, further experiments monitoring P. berghei development in A. gambiae, 
successfully conducted in the host lab (D. Vlachou, personal communication), disclosed a 
pungent effect of the deletion of these genes. Specifically, consistent with the results from the A. 
stephensi infections, all four transgenic lines presented severe reduction in the oocyst numbers 
compared to the WT, with ΔPb_c53 presenting, again, the most outstanding phenotype.  
Also, ookinete motility assay revealed that Pb_c01 deletion has no effect in the ookinete 
motility and invasive ability, with the ΔPb_c01 transgenic line producing normally motile 
ookinetes, compared to the WT (D. Vlachou, personal communication). This proposes that 
Pb_c01 gene is most probably involved in the stage of ookinete-to-oocyst transformation, 
consistent with its P. falciparum ortholog’s transcriptional peak in this stage (Figure 4.4). 
Overall, the results derived from the continuation of the phenotypic analysis of these four 
transgenic lines in the host lab reinforce the major conclusion of this thesis that all four genes 
play a substantial role during the period of the severest bottleneck in the parasite’s sexual 
development, the ookinete invasion and transformation to oocyst. Specifically, the Pb_c53 and 
Pb_c22 which have no predicted transmembrane domains or signal peptide motifs (allowing for 
no in silico based predictions about putative functions to be made) are most probably responsible 
for the successful development of P. berghei during the midgut invasion and ookinete-to-oocyst 
transition stages. On the other hand, the Pb_c01 and Pb_c57, based on the predicted protein 
structures which include both signal peptide motif and a transmembrane domain, are most likely 
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to produce molecules that putatively interact with mosquito midgut molecules, possibly 
facilitating midgut invasion, and thus candidates for TBV interventions.  
Undoubtedly, transcriptional regulation of these four genes plays a key role in the 
efficacy of P. berghei sexual development and transmission, suggesting that their P. falciparum 
orthologs are most likely to have a similar role, based on their expression profiles (Figure 4.4) 
and their predicted protein structures (Figure 4.6). 
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CHAPTER 6: CONCLUDING REMARKS AND FUTURE RESEARCH 
PERSPECTIVES 
 
The successful targeted gene disruption of four P. berghei candidates and their detailed in 
vitro and in vivo phenotypic analysis identified four novel genes that have crucial roles, as 
demonstrated for the first time, during the stages between ookinete maturation and oocyst 
formation and are really important for rodent malaria transmission. This study has provided 
precious information that could be exploitable towards the elucidation of key gaps in the 
knowledge of the parasite mechanisms that are recruited during its development inside the 
mosquito vector and has, also, revealed two novel potential targets for the deployment of new 
transmission blocking interventions.   
The extensive phenotypic analysis conducted during this study, identified key regulators 
of sexual development of the malaria parasite in the mosquito midgut and novel targets for TBV 
interventions.  Future work will elucidate the exact function of these four novel genes. Future 
work will encompass the completion of this phenotypic analysis, including in vivo ookinete 
invasion assays for all the transgenic parasite lines in order to determine the transgenic ookinete 
motile behaviour and invasive ability (already performed for Pb_c01 in the host lab). By these 
assays it will be possible to specify whether the gene products are involved in the development 
of these parasite abilities or they regulate later developmental stages. 
Complementation experiments, including the replacement of P. berghei genes with the P. 
falciparum orthologs (knock in), could also be performed. By these means, the hypothesis that 
the orthologous genes have a conserved function at the same time point of the development of 
the two different parasite spp could be illuminated if there is rescue of KO the phenotype, or vice 
versa.   
The research should be continued with the cloning of these P. falciparum genes in 
expression vectors for the production of the human malaria parasite proteins, a procedure already 
initiated in the host lab. These proteins can be used for the generation of native antibodies 
targeting the products of the identified genes, which will assist localisation experiments that will 
shed light on their subcellular localisation, and consequently their function, utilising confocal 
microscopy. 
 Apart from the utility of the native antibodies in the localisation experiments, they will, 
most importantly, be used in order to reach the long-term goal, the development of TBV. The 
products of Pf_c01 and Pf_c57, which are putatively surface proteins of the parasite, comprise 
extremely intriguing targets for this approach. Antibody inhibition assays, performed in the field, 
will evaluate the capability of the generated antibodies to inhibit the sexual development of 
Plasmodium and the potential of these antigens as transmission blocking intervention targets.  
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ABBREVIATIONS 
 
 
AMA  Apical Membrane Antigen 
ANKA  Anvers/Kasapa 
APL   Anopheles Plasmodium-responsive Leucine-rich repeat 
Apo   Apolipophorin 
AT   Adenine-Thymine 
ATP   Adenosine TriPhosphate 
 
BC   Before Christ 
bp   base pair 
BSA   Bovine Serum Albumin 
 
C57BL/6  C57 Black 6 
CAP   Capsule Protein 
CDPK  Calcium Dependent Protein Kinase 
cDNA   complementary DNA 
CHIT   Chitinase   
CSP   CircumSporozoite Protein 
CTL   C-Type Lectin 
CTP  Citidine TriPhosphate 
CTRP   Circumsporozoite and TRAP Related Protein 
 
DAPI   4',6-diamidino-2-phenylindole 
DDT   DichloroDiphenylTrichloroethane 
DHFR-TS  DiHydroFolate Reductase-Thymidilate Synthase 
DNA   DeoxyriboNucleic Acid 
DOZI   Development Of Zygote Inhibited 
 
ECP   Egress Cysteine Protease 
EDTA  Ethylene Diamine Tetraacetic Acid 
EGF   epidermal growth factor 
eGFP   enhanced Green Fluorescent Protein 
ER   Endoplasmic reticulum 
 
F   Forward 
FCS   Foetal Calf Serum 
FBS  Foetal Bovine Serum 
 
GPI   Glycosylphosphatidylinositol 
GTP   Guanosine TriPhosphate 
 
Hepes   4-(2-HydroxyEthyl)-1-Piperazine Ethane Sulfonic acid 
 
IM   Intra-Muscular 
INT   Integration 
IP   Intraperitoneal 
RNAi   RNA interference 
IRS   Indoor Residual Spraying 
ITN   Insecticide Treated Nets 
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KD   Knock-Down 
KO   Knock-Out 
 
LAN   Laminin 
LAP   LCCL/lectin adhesive- like protein 
LB   Luria broth 
LCCL   Limulus Clotting factor C, Coch-5b2 and Lgl1 
LRIM   Leucine Rich-Repeat Immune gene 
 
mAb   monoclonal Antibody 
MACPF  Membrane Attack Complex Perforin 
MAEBL  Merozoite AMA1/Erythrocyte Binding Ligand-like protein 
MAPK  Mitogen-Activated Protein Kinase 
Mg   Milligram 
μg   microgram 
MISFIT  Male-Inherited Sporulation Factor Important for Transmission 
mL   milliLiter 
μL   microLiter 
mRNA  messenger RNA 
MSP   Merozoite Surface Protein 
MTOC  MicroTubule Organising Centre 
 
ng   nanogram 
Nek   NIMA related kinase 
NIAID  National Institute of Allergy and Infectious Diseases 
NIMA  Never-in-mitosis/Aspergillus 
NOS   Nitric Oxide Synthase 
 
ORF   Open Reading Frame 
 
PBS   Phosphate-Buffered Saline 
pBS   pBluescript 
PCR   Polymerase Chain Reaction 
PH   PhenylHydrazinium chloride 
P.I.   Post infection 
(P)PO   (Pro)PhenolOxidase 
PPLP   Plasmodium Perforin-Like Protein 
PSOP   Putative Secreted Ookinete Proteins 
PV   Parasitophorous vacuole 
 
R   Reverse 
RBC   Red Blood Cell 
RDT   Rapid Diagnostic Tests 
RNA   Ribonucleic acid 
RPMI   Roswell Park Memorial Institute 
RT-PCR  Reverse Transcriptase PCR 
 
SE   Standard Error 
Serpin   Serine protease inhibitor 
SOAP   Secreted Ookinete Adhesive Protein 
Spp  Species (plural) 
SRPN   Serpin 
Institutional Repository - Library & Information Centre - University of Thessaly
09/12/2017 03:13:53 EET - 137.108.70.7
94 
 
 
TBE   Tris-Borate-EDTA 
TEP   Thioester-containing protein 
TBE   Tris-borate-EDTA 
TBV   Transmission blocking Vaccine 
TgDHFR-TS  Toxoplasma gondii DiHydroFolate Reductase-Thymidilate Synthase 
Tm   Template Melting temperature 
TO   Theiler’s Original 
TRAP   Thrombospondin-related adhesive protein 
TTP  Thymidine TriPhosphate 
 
UTR   UnTranslated Region 
 
WARP  von Willebrand Factor A domain-Related Protein 
WASP  Wiskott–Aldrich Syndrome Protein 
WHO   World Health Organisation 
WT   Wild Type 
 
XA   Xanthurenic Acid 
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